XM-DAC-30010-DolPHIN2 Unitaid The goal is to enable the reduction of the rate of mother to child transmission of HIV from late-presenting HIV-positive pregnant women. University of Liverpool Unitaid Danielle Ferris Programme Manager ferrisd@unitaid.who.int 8530 762763 2276711 1835889 1273669 1939413 2484323 866802 225062 Unitaid University of Liverpool 96101 Unitaid University of Liverpool 422131 Unitaid University of Liverpool 1330000 Unitaid University of Liverpool 1845000 Unitaid University of Liverpool 1617864 Unitaid University of Liverpool 806626 Unitaid University of Liverpool 752727 Unitaid University of Liverpool 677162 337030 957055 Unitaid University of Liverpool 1350000 Unitaid University of Liverpool 276000 Unitaid University of Liverpool 10924812 Grant Agreement Value XM-DAC-30010-NAMSALCT Unitaid he NAMSAL trial, which is sponsored and co-funded by the French National Agency of Research on AIDS & Hepatitis (ANRS) and would be implemented by the Institut Bouisson Bertrand (IBB) and the Institut de Recherche pour le Développement (IRD), aims to generate robust evidence on the clinical and economic benefits of a dolutegravir (DTG)-based regimen in an African setting, representative of real-world conditions within resources-constrained settings. The study protocol has been reviewed and approved by the appropriate authorities. UNITAID is requested to co-fund this trial by supporting the purchase of the study drugs for the duration of the 48-week trial, and after completion of the trial for a duration of up to three years for post-trial access if the new regimen is not yet accessible by then to the study participants via the National Program. Institute Bouisson Bertrand ANRS Unitaid Operations Danielle Ferris Programme Manager +41 22 791 12 00 ferrisd@unitaid.who.int https://unitaid.org/ Chemin du Pommier 40, 5th floor, 1218 Grand-Saconnex Geneva, Switzerland 178204 365199 369976 528566 493281 1326086 315000 Unitaid Institut Bouisson Bertrand (IBB) 144507 Unitaid Institut Bouisson Bertrand 3261312 Grant Agreement Value. The value of the grant increased by $4172,532, due to Covid 19 resolution. 299441 Unitaid Institut Bouisson Bertrand 293944 Unitaid Institut Bouisson Bertrand 400550 Unitaid Institut Bouisson Bertrand 219396 Unitaid Bouisson Bertrand Institute 401000 102000 70000 Unitaid Institut Bouisson Bertrand (IBB) 540000 Unitaid Institut Bouisson Bertrand 172532 COVID-19 Unitaid Institut Bouisson Bertrand XM-DAC-30010-utd-chai_poc2a Unitaid The project intends to prepare the market for accelerated scale-up of POC HIV Dx: CD4, VL and EID by working with 7 high-volume early adopter countries to prepare for rapid scale-up of POC Dx, while helping new suppliers through the regulatory and policy approval processes Clinton Health Access Initiative UNICEF UNITAID Beginning of 2016 September 2014 UNITAID Smiljka De Lussigny 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 2915000 CHAI 5100000 CHAI 14220000 UNICEF 1030000 UNICEF 4866819 CHAI 2509000 UNICEF 2527188 Cumulative disbursements for the year 35000000 CHAI XM-DAC-30010-Wambo Unitaid To generate savings and increase access to health products and related commodities by facilitating healthy markets to better utilize resources in the fight against the three diseases (AIDS, tuberculosis, malaria) The Global Fund to Fight AIDS, Tuberculosis and Malaria Unitaid Sina Zintzmeyer Programme Officer zintzmeyers@unitaid.who.int 1172454 950000 Unitaid The Global Fund to Fight AIDS, Tuberculosis and Malaria 1085000 Unitaid The Global Fund to Fight AIDS, Tuberculosis and Malaria 5767347 Grant Agreement Value Unitaid The Global Fund to Fight AIDS, Tuberculosis and Malaria XM-DAC-30010-OPP-ERAPh2 Unitaid To contribute to the scaled-up access to VLT in LMICs through increased demand and use of OPPs for VL testing and EID in the four target countries. Solthis Unitaid Smiljka de Lussigny Programme Manager delussignys@unitaid.who.int 5260996 2443554 1991180 Unitaid Solthis 1500000 Unitaid Solthis 14704965 Grant Agreement Value 3292128 4080000 Unitaid Solthis 2536000 Unitaid Solthis 275068 Unitaid Solthis XM-DAC-30010-CuPOCph2b Unitaid To accelerate access to innovative point of care diagnostics, jointly implemented by Clinton Health Access Initiative (CHAI) and United Nations Children’s Fund (UNICEF), in 7 high burden countries UNICEF Clinton Health Access Initiative Unitaid Smiljka de Lussigny Programme Manager delussignys@unitaid.who.int 28419526 21466634 6787604 25710595 11970099 2461254 Clinton Health Access Initiative 1000000 Unitaid CHAI 500000 Unitaid UNICEF Supply Division 2301062 Unitaid UNCEF Supply Division 776617 Clinton Health Access Initiative 7265037 Unitaid Clinton Health Access Initiative 4777000 2560096 Clinton Health Initiative Foundation 2038897 Unicef 3825630 Unitaid Clinton Health Access Initiative 977481 Unitaid Unicef 7491667 Unitaid Clinton Health Access Initiative 2060778 Unitaid Clinton Health Access Initiative 966442 Unitaid Unicef 836962 Unitaid Unicef 220000 Unitaid UNICEF Program Division 2549051 Unitaid William Clinton Foundation HIV/AIDS Initiative Unitaid Fund 1036153 Unitaid 362081 UNICEF 77559 Unitaid UNICEF PD 582703 Unitaid UNICEF SD 5293240 Unitaid WILLIAM CLINTON FOUNDATION HIV/AIDS INITITIAVE UNITAID FUND (CHAI) 2482363 Unitaid Clinton Health Initiative Access 94354458 Amended Grant Agreement Value (after grant reprogramming in 2019) Unitaid CHAI XM-DAC-30010-utd-c+_hiv/hcv Unitaid The grant is attempting to stimulate demand for HCV care in selected countries by raising awareness by engaging with civil society organizations and local decision makers. Coalition Plus UNITAID Includes Costed Extension, January 2018-December 2018. 2nd Costed extension, 2019-2020 Unitaid Katherine Hencher Programme Manager +41 22 791 12 00 hencherk@unitaid.who.int Chemin de Blandonnet 10 – BIBC III – 8th Floor 1214 Vernier, Switzerland 561405 2165407 Unitaid Coalition Plus 213633 Unitaid Coalition Plus 1154932 Costed Extension agreement value Unitaid Coalition Plus 408886 Unitaid Coalition plus 5230000 Coalition Plus Indonesia, Malaysia, Thailand, Colombia, Morocco 816490 Indonesia, Malaysia, Thailand, Colombia, Morocco 1102504 Indonesia, Malaysia, Thailand, Morocco, Colombia 878068 Indonesia, Malaysia, Thailand, Colombia, Morocco 452172 Coalition Plus Indonesia, Malaysia, Thailand, Colombia, Morocco 3758148 Increase of the Grant Funding Ceiling for Phase 1c of the project. Total Grant Funding Ceiling for all phases is $10,143,080 Unitaid Coalition plus 1164244 Unitaid Coalition Plus 64662 Unitaid COALITION INTERNATIONAL SIDA 591247 Unitaid Coalition Plus 1250718 Unitaid Coalition Internationale SIDA - PLUS 442327 Unitaid Coalition Internationale SIDA - Plus XM-DAC-30010-utd-chai_ipma Unitaid IPMA builds on the UNITAID Paediatric Project by providing greater market stability without requiring a commodity donation. The project aims to ensure 630,000 patients currently on treatment as well as HIV-exposed infants have continued access to critical, life-saving ARVs and that further scale-up efforts to reach the remaining 2 million children in need of immediate treatment are supported with the stable supply and pricing of optimal paediatric HIV commodities Clinton Health Access Initiative UNITAID End of 2016 January 2014 UNITAID Ekaterina Rykovanova 41227915503 rykovanovae@who.int 660750 CHAI 660750 CHAI 11630000 1786490 501000 CHAI 4786400 CHAI 1297000 338825 XM-DAC-30010-utd-dndi_peds Unitaid The Project will be implemented with a view to increasing access to optimal ART for children under three years and will involve the development of three products through the DNDi’s partnership with Cipla Drugs for Neglected Diseases initiative (DNDi) UNITAID UNITAID Ekaterina Rykovanova Programme Manager +41 22 791 12 00 rykovanovae@who.int Chemin de Blandonnet 10 – BIBC III – 8th Floor 1214 Vernier, Switzerland 2971489 2146822 Unitaid Drugs for Neglected Diseases 644893 Unitaid Drugs for Neglected Diseases initiative (DNDi) 1978904 Unitaid Drugs for Neglected Diseases 17335404 Drugs for Neglected Diseases initiative (DNDi) 4945000 Unitaid Drugs for Neglected Diseases initiative (DNDi) 755388 Unitaid Drugs for Neglected Diseases initiative (DNDi) 2173805 Unitaid Drugs for Neglected Diseases initiative (DNDi) 2940621 Unitaid Drugs for Neglected Diseases initiative (DNDi) 1171410 Unitaid Drugs for Neglected Diseases initiative (DNDi) 565355 Unitaid Drugs for Neglected Diseases initiative (DNDi) 395923 Unitaid Drugs for Neglected Diseases initiative (DNDi) XM-DAC-30010-utd-who_xpert Unitaid The TBXpert Project will scale up TB diagnostic testing using state-of-the-art Xpert MTB/RIF, providing approximately 1.4 million Xpert MTB/RIF test cartridges and over 200 GeneXpert instruments for the rapid detection of TB and rifampicin resistance in 21 recipient countries. To ensure country absorptive capacity and effective use of the technology, the TBXpert project links a broad network of partners and existing initiatives for TB laboratory strengthening to expand access to vulnerable populations in the public and private sector World Health Organisation - assessed contributions ASLM IRD UNITAID UNITAID Robert Matiru 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 42500 ASLM 126140 IRD 163300 IRD 70000 ASLM 3117636 World Health Organisation - assessed contributions 3476392 World Health Organisation - assessed contributions 332955 World Health Organisation - assessed contributions 2738700 World Health Organisation - assessed contributions 6484323 World Health Organisation - assessed contributions 75000 ASLM 367735 World Health Organisation - assessed contributions 106444 IRD 716662 World Health Organisation - assessed contributions 25899970 World Health Organisation - assessed contributions 7068500 World Health Organisation - assessed contributions 266333 IRD 327757 World Health Organisation - assessed contributions 169945 37500 ASLM 119793 IRD 346981.65 Reimbursement from the grantee Stop TB Partnership Unitaid 4517 ASLM Unitaid XM-DAC-30010-utd-act_watch2 Unitaid Market intelligence for malaria products Population Services International (PSI) Population Service International Middle of 2017 June 2014 UNITAID Alexandra Cameron 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 450000 Unitaid Population Services International 1090661 Unitaid Population Services International 217722 Unitaid Population Services International 2800000 Unitaid Population Services International 300000 Unitaid Population Service International 620000 Unitaid Population Service International 100000 Unitaid Population Service International 30279 XM-DAC-30010-utd-drw_samba Unitaid The project aims to implement SAMBA for EID and VL in seven countries. Phase 1 will involve independent evaluation in reference laboratories before feasibility studies at lower-level health care settings. The final phase of the project will be to implement SAMBA in 10-20 sites in each of the project countries Diagnostics for the Real World UNITAID End of 2016 January 2014 UNITAID Danielle Ferris 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 4187906 Diagnostics for the Real World 8843600 Diagnostics for the Real World 2940621 Diagnostics for the Real World 1713477 XM-DAC-30010-utd-egpaf_poc Unitaid This project aims to increase the number of HIV-positive infants whose HIV status is known in order to facilitate early ART initiation. The specific purpose is to ensure that at-risk infants have timely access to early infant diagnosis (EID) of HIV through the scale-up of point-of-care (POC) EID in nine countries: Cameroon, Côte d’Ivoire, Kenya, Lesotho, Mozambique, Rwanda, Swaziland, Zambia, and Zimbabwe. Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) UNITAID Middle of 2019 August 2015 UNITAID Smiljka De Lussigny 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 776069 4910839 12082942 19489156 9376867 2539145 8138000 Unitaid Elizabeth Glaser Pediatric AIDS Foundation 10015640 Unitaid Elizabeth Glaser Pediatric AIDS Foundation 4000000 Unitaid Elizabeth Glaser Pediatric Aids Foundation 5351775 Elizabeth Glaser Paediatric AIDS Foundation 3340000 Unitaid Elizabeth Glaser Pediatric AIDS Foundation 63082069 Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) 4195000 Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) 8956000 318400 Unitaid EGPAF 2850826 Unitaid EGPAF 4050000 Unitaid Elizabeth Glaser Pediatric AIDS Foundation 45904.9 Unitaid ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION XM-DAC-30010-utd-lshtm Unitaid Three year project focused on improving the enabling environment for POC HIV diagnostics. Proponent plans to develop quality standards, an evaluation protocol, a global network of POC technology evaluation sites and a Toolkit to facilitate evaluation and adoption London School of Hygiene & Tropical Medicine UNITAID Middle of 2016 July 2013 UNITAID Smiljka de Lussigny delussignys@unitaid.who.int 1000000 London School of Hygiene & Tropical Medicine 4927750 LSHTM 940000 LSHTM 1159882 LSHTM 675000 LSHTM -225000 LSHTM 420747 XM-DAC-30010-utd-mc_smc Unitaid The project aims to expand seasonal malaria chemoprevention (SMC) in 7 countries (Burkina Faso, Chad, Guinea, Mali, Niger, Nigeria, The Gambia), in order to accelerate impact and build markets for SMC products Malaria Consortium Malaria consortium UNITAID Ana Alvarez Nieto alvareznietoa@who.int 704586 Unitaid Malaria Consortium 6505465 800000 Costed Extension Value Unitaid Malaria Consortium 7400942 Unitaid Malaria Consortium 735958 Unitaid Malaria Consortium 67434637 Unitaid Malaria Consortium 10483000 Unitaid Malaria Consortium 2652289 Unitaid Malaria Consortium 11718964 Unitaid Malaria Consortium 27850279 Unitaid Malaria Consortium XM-DAC-30010-utd-mmv_as Unitaid The goal of this project led by MMV in collaboration with CHAI and Malaria Consortium is to contribute to the reduction in mortality from severe malaria through the accelerated global adoption of injectable artesunate and availability of artesunate suppository Medicines for Malaria Venture (MMV) UNITAID Middle of 2016 June 2013 UNITAID Ambachew Yohannes 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 34000000 MMV 630000 MMV 1241557 MMV 4844156 MMV 3420000 MMV 573000 MMV 8483616 MMV 840728 XM-DAC-30010-utd-mpp2 Unitaid The aim of the Foundation is to remove market entry barriers for generic ARVs through "pro-public health" voluntary licenses, in as many countries as possible, and to facilitate the development of FDCs and paediatric formulations. MPP Foundation UNITAID End of 2020 January 2016 UNITAID Katherine Hencher hencherk@unitaid.who.int Chemin de Blandonnet 10 – BIBC III – 8th Floor 1214 Vernier, Switzerland 5913765 5913792 5911016 3060000 Unitaid Medicines Patent Pool Foundation 2798000 Unitaid Medicines Patent Pool Foundation 2857000 Unitaid Medicines Patent Pool Foundation 1500000 Unitaid Medicines Patent Pool 2130000 Unitaid Medicines Patent Pool 1022000 Unitaid Medicines Patent Pool Foundation 1171000 Unitaid Medicines Patent Pool Foundation 29215571 MPP Foundation 6283470 1545000 2035000 Unitaid Medicines Patent Pool Foundation 2931974 Unitaid Medicines Patent Pool Foundation XM-DAC-30010-utd-msf_hcv Unitaid The 3-year project plans to shape sustainable markets to ensure those living with HIV-HCV in low- and middle-income countries have rapid access to products for HCV, taking advantage of changes to the HCV landscape, including entry of directly-acting antivirals (DAAs) that are administered orally Medicins sans Frontiers (MSF) UNITAID Middle of 2017 January 2015 UNITAID Katherine Hencher 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 14981330 Doctors Without Borders 1908819 2005000 Doctors Without Borders 3150524 Unitaid Medicines sans Frontieres XM-DAC-30010-utd-opp_era Unitaid The Project improves access to viral load testing (VLT) and early infant diagnosis (EID) for adults and children living with HIV through the introduction of innovative Open Polyvalent Platforms (OPPs). During Phase I of the Project, the lead project implementer, France Expertise International (FEI), will work with other partners to develop a full Business Plan for scaled-up commercialization of VLT/OPP, prepare a proposal for the second phase of the Project, develop a procurement strategy and plan for the 4 project target countries  and commence deployment on OPPs in these countries France Expertise International (FEI) UNITAID UNITAID Smiljka De Lussigny 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 232718 FEI 2400000 FEI 406797 FEI 4000000 FEI 2914438 FEI 243762 FEI 476723 FEI 1040000 FEI 385355 20258 XM-DAC-30010-utd-lc_patent Unitaid This project aims to prevent the creation of patent-based market entry barriers, or, where such barriers already exist, remove them, for medicines for HIV, TB and hepatitis C, as well as other HIV co-infections agreed to by UNITAID approved and under development) Lawyers Collective UNITAID Middle of 2016 August 2013 UNITAID Ekaterina Rykovanova rykovanovae@who.int 677100 Lawyers Collective 83711 Lawyers Collective 55000 Lawyers Collective 62000 Lawyers Collective 88700 Lawyers Collective 65000 XM-DAC-30010-utd-step_tb Unitaid The project aims to increase and accelerate the availability of properly formulated, appropriately dosed international-standard quality paediatric tuberculosis (TB) medicines. The project will act as a market catalyst and creator by facilitating adoption and uptake of improved paediatric TB medicines, and by making it appealing to manufacturers to produce medicines that address a major public health issue TB Alliance World Health Organisation (WHO) UNITAID Middle of 2016 July 2013 UNITAID Robert Matiru 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 16606096 TB Alliance 238724 TB Alliance 452000 TB Alliance 4879312 TB Alliance 3412000 TB Alliance 807340 TB Alliance 3606000 TB Alliance 1492747 WHO 30240 TB Alliance 602000 Unitaid World Health Organisation XM-DAC-30010-utd-tides_itpc Unitaid The project aims to use TRIPS flexibilities to remove barriers to generic competition for 2nd and 3rd line ARVs. This will result in lower prices in four intervention countries (Argentina, Brazil, Thailand, Ukraine) and expand the overall market for newer ARVs. In addition, the proponents will work toward reform of intellectual property (IP) laws or regulations in order to facilitate continued/future use of such flexibilities International Treatment Preparedness Coalition (ITPC) UNITAID UNITAID Ekaterina Rykovanova rykovanovae@who.int 2120997 323592 298453 Unitaid International Treatment Preparedness Coalition (ITPC) 6000000 Unitaid International Treatment Preparedness Coalition (ITPC) - Tides Centre 800000 Unitaid TIDES-International Treatment Preparedness Coalition (ITPC) 1641408 Unitaid International Treatment Preparedness Coalition (ITPC) - Tides Centre 1000000 Unitaid International Treatment Preparedness Coalition (ITPC) - Tides Centre 2235000 Unitaid International Treatment Preparedness Coalition (ITPC) - Tides Centre XM-DAC-30010-WITSRHIADVANCE Unitaid The goal of this project is to contribute to scale-up of improved regimens for use in first-line ARV treatment in LMICs. These new regimens will be more effective and cheaper than the current standard of care. This will help to reach the UNAIDS 90-90-90 targets, particularly getting to 90% of people on treatment and 90% of those being virally suppressed. Wits Reproductive Health and HIV Institute Unitaid Katherine Blumer Programme Manager 41227911200 blumerK@unitaid.who.int https://unitaid.org/#en 37894 2419295 3159239 3034618 3194048 5108063 3381171 133037 1648500 1670644 468120 Wits University 1490457 Unitaid Wits RHI 1788944 Unitaid Wits Reproductive Health and HIV Institute (Wits RHI) 2999416 Unitaid Wits RHI 274434 Unitaid Wits Reproductive Health and HIV Institute (Wits RHI) 1290000 Unitaid Wits Reproductive Health and HIV Institute (Wits RHI) 2200000 Unitaid Wits Health Consortium (Pty) Wits 3455000 Unitaid Wits Health Consortium 947736 Unitaid Wits Health Consortium (Pty) Ltd (WHC) (Ezintsha Division) 512157 Unitaid Wits Health Consortium (Pty) Ltd (WHC) (Ezintsha Division) 22851279 Grant Agreement Value 2140000 Unitaid Wits XM-DAC-30010-utd-msf_hivdx Unitaid MSF engages in operational research on introduction of PoC and adapted laboratory-based monitoring to understand how, where and when PoC fits in the mix of laboratory services available in the health services. Eleven different MSF-supported HIV/AIDS programs in the seven project countries engage in complementary work to compare different strategies and identify the most feasible and affordable options for optimal deployment and use of diagnostic tests in given types of resource-constrained settings Medicins sans Frontiers (MSF) UNITAID UNITAID Smiljka De Lussigny 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 28696023 7715000 361385 2145000 3515000 4185000 2081571 Medicins sans Frontiers 7473496 Unitaid Medicines sans Frontiers XM-DAC-30010-utd-psi_rdts Unitaid PSI and the collaborating implementers, Malaria Consortium (MC), FIND, and WHO/Global Malaria Programme (GMP), will stimulate the creation of a private sector market for malaria RDTs.  The partnership will operate in five target countries  where the UNITAID-supported AMFm has been implemented.  The project is designed as a  catalytic market intervention to develop methods and to learn and to disseminate experience and project lessons learned to accelerate the introduction and scale up of malaria RDTs in the private sector Population Services International World Health Organisation - assessed contributions UNITAID UNITAID Ambachew Yohannes Programme Manager yohannesam@unitaid.who.int 2618245 Population Services International 275722 Population Services International 2268477 Population Services International 1622584 Population Services International 1698567 Population Services International 3338000 Population Services International 3000000 Population Services International 3338000 Population Services International 1260030 2000000 Population Services International 250000 443449 34290560 Population Services International 1395232 Return of funds 100000 501098 XM-DAC-30010-utd-find_qardt Unitaid The goal of this project is to establish sustainable standards to ensure that quality malaria RDTs are increasingly used to support rationale treatment of malaria in endemic countries. FIND will coordinate implementation of the RDT product and lot testing services in collaboration with WHO/GMP. FIND and partners will establish and employ RDT quality control procedures and will develop and pilot the introduction of recombinant antigen-based evaluation panels FIND World Health Organisation UNITAID End of 2017 January 2013 UNITAID Ambachew Yohannes 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 225000 Unitaid WHO Global Malaria Programme 784000 Unitaid Foundation for Innovative New Diagnostics 468279 Unitaid Foundation for Innovative New Diagnostics 251361 Unitaid World Health Organization, Global Malaria Programme 186450 FIND 543000 FIND 224305 FIND 603903 FIND 246960 FIND 9441777 FIND 1136000 FIND 1028000 Cumulative disbursements for the year FIND 1631000 Cumulative disbursements for the year 450000 FIND 610950 FIND XM-DAC-30010-utd-who_pqdx2 Unitaid The project aims to increase the number of quality assured tools to diagnose and monitor treatment for HIV/AIDS and malaria. The project also provides support to strengthen regulatory capacity and post marketing surveillance of diagnostic tests in five pilot countries. World Health Organisation UNITAID covering the no-cost and cost-extension periods of the project UNITAID Katherine Hencher hencherk@unitaid.who.int 1459960 World Health Organisation - assessed contributions 12166680 World Health Organisation - assessed contributions 1373063 World Health Organisation - assessed contributions 2915400 World Health Organisation - assessed contributions 3641388 Cumulative disbursements for the year 947372 XM-DAC-30010-utd-who_pqmeds2 Unitaid The Medicines Quality Assurance project aims to increase the number of prequalified UNITAID priority medicines for HIV/AIDS, TB and malaria as well as 1) increasing capacity in production of quality medicines, 2) facilitating the development of national regulatory processes and 3) Accelerating testing of the quality of medicines. For 2018 the budget of the project covers both Medicine and Diagnostics activities World Health Organization UNITAID Covers non-cost and cost-extension of the project UNITAID Katherine Hencher Programme Manager hencherk@unitaid.who.int 14387190 5387047 Unitaid World Health Organization 76736 World Health Organization Unitaid 11853015 Disbursement under costed extension agreement for both PQ Meds and PQ Dx projects Unitaid World Health Organization 21444475 Costed Extension Agreement Value for PQ Meds and PQ Dx World Health Organization 2266328 World Health Organisation - assessed contributions 38136728 World Health Organisation - assessed contributions 971800 World Health Organisation - assessed contributions 4678200 World Health Organisation - assessed contributions 9312330 World Health Organisation - assessed contributions 11557030 Cumulative disbursement value for the year 4142074 XM-DAC-30010-TIPTOP Unitaid The project will create a pathway based on local evidence and buy-in to sustain and scale up an innovative, community-based approach to expand coverage of intermittent preventive treatment in pregnancy (IPTp) for pregnant women, in four project countries and eventually across sub-Saharan Africa (SSA). Jhpiego Unitaid Ana Alvarez Nieto Programme Manager +41 22 791 12 00 alvareznietoa@who.int Chemin de Blandonnet 10 – BIBC III – 8th Floor 1214 Vernier, Switzerland 1766997 7220766 11318035 11252735 11140896 3872242 9568191 Unitaid JOHNS HOPKINS UNIVERSITY CENTRAL LOCKBOX - JHIEPO 2423984 Unitaid Jhpiego 4119557 Unitaid Jhpiego 6643646 6211430 Unitaid Jhpiego Corporation 3959011 Unitaid Jhpiego 5846225 Unitaid Jhpiego 439925 Unitaid Jhpiego Corporation 51593329 1700424 Unitaid Jhpiego Corporation 4500000 Unitaid JOHNS HOPKINS UNIVERSITY CENTRAL LOCKBOX XM-DAC-30010-utd-mpp Unitaid This project aims to bring down the prices of HIV medicines and facilitate development of better-adapted HIV medicines, such as fixed-dose combinations (FDCs) and special formulations for children, by creating a pool of relevant patents for licensing to generic manufacturers and product development partnerships MPP Foundation UNITAID UNITAID Katherine Hencher 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 1734005 MPP Foundation 712891 MPP Foundation 5150982 MPP Foundation 1403785 MPP Foundation 2440971 MPP Foundation 2352000 MPP Foundation 31151121 MPP Foundation 825000 MPP Foundation 2063713 MPP Foundation 2197644 MPP Foundation 2043000 MPP Foundation 3033000 MPP Foundation XM-DAC-30010-CHAIRAS Unitaid Project aims at increased access to QA rectal artesunate as a part of strengthened severe malaria management systems. Clinton Health Access Initiative Unitaid Ana Alvarez Nieto Programme Manager +41 22 791 12 00 alvareznietoa@who.int Chemin de Blandonnet 10 – BIBC III – 8th Floor 1214 Vernier, Switzerland 729948 3880837 5991109 6271139 820077 2326557 UNITAID CHAI 1543737 UNITAID UNICEF 19166811 Grant Agreement Value 2854493 Unitaid Clinton Health Access Initiative (CHAI) 2051725 Unitaid Clinton Health Access Initiative 1552641 Unitaid CHAI 915342 Unitaid Clinton Health Access Initiative 638281 Unitaid UNICEF 1145165 Unitaid Unicef 1400346 Clinton Health Access Initiative 1253307 Unitaid Clinton Health Access Initiative 1424446 Unitaid Clinton Health Access Initiative 1142527 Unitaid Clinton Health Access Initiative XM-DAC-30010-RTS,S Unitaid This project aims to operationalize the WHO recommendation for pilot implementation of the new malaria vaccine, RTS,S/AS01, and the evaluation of feasibility, impact, and safety of the vaccine when used in a routine immunization programme. The overall goal of the Malaria Vaccine Implementation Programme is to achieve a WHO policy recommendation on the use of the RTS,S/AS01 malaria vaccine in young children in sub-Saharan Africa. World Health Organization Unitaid Ambachew Yohannes Programme Manager +41 22 791 12 00 yohannesam@unitaid.who.int https://unitaid.eu 2768909 3015456 2588710 828985 Unitaid WHO 1858658 Unitaid World Health Organization 1967132 Unitaid World Health Organization 9600000 Grant Agreement Value 1070020 Unitaid World Health Organization XM-DAC-30010-HIVenablerST Unitaid Support by WHO for Unitaid's HIV Self-Testing (HIVST) portfolio World Health Organization Unitaid Eva Nathanson Team Lead, Operations +41 22 791 12 00 https://unitaid.eu 336033 1135675 1098385 883865 3453959 Grant Agreement Value 499361 XM-DAC-30010-MTV_SAF Unitaid This grant will create demand for HIVST and PrEP among young people (15-24) in South Africa and Côte d'Ivoire by developping 3 TV Shuga series. It uses a 360 approach consisting of an array of tools (graphic novels, peer guides, radio programmes, social media) to reach the highest number of at risk youth possible. MTV Staying Alive Foundation Unitaid Operations Heather Ingold Programme Manager +41 22 791 12 00 unitaid@who.int https://unitaid.eu Chemin du Pommier 40, 5th floor, 1218 Grand-Saconnex Geneva, Switzerland 1395594 2949594 2848855 1608546 860610 1303000 Unitaid MTV Staying Alive Foundation 802000 Unitaid Staying Alive Foundation 300000 Unitaid MTV Staying Alive Foundation 12338441 Grant Agreement Value, the value was increased by $300,000, after Amended face sheet due to Covid 19 Unitaid MTV Staying Alive Foundation 443470 Unitaid The Staying Alive Foundation Inc. 1243559 Unitaid Staying Alive Foundation MTV Shuga 945000 Unitaid Staying Alive Foundation MTV Shuga 2220000 Unitaid MTV Staying Alive Foundation 3185000 Unitaid MTV Staying Alive Foundation 1766926 Unitaid The Staying Alive Foundation Inc. XM-DAC-30010-Solthis_ATLAS Unitaid Increasing access to self-testing for HIV (HIVST) among target populations, promote linkage to prevention, care and treatment, thereby reducing the number of HIV infections, HIV related deaths, and disability adjusted life years. Solthis Unitaid Heather Ingold Programme Manager +41 22 791 12 00 ingoldh@unitaid.who.int https://unitaid.org/ Chemin de Blandonnet 10 – BIBC III – 8th Floor 1214 Vernier, Switzerland 914631 3813718 4659768 4849730 1479017 4148000 Unitaid Solthis 36473 Unitaid Solthis 860000 Unitaid SOLTHIS 15716863 Grant Agreement Value Unitaid Solthis 1104000 Unitaid Solthis 4000000 Unitaid Solthis 190263 Unitaid Solthis 1311034 Unitaid SOLTHIS 2175000 Unitaid Solthis 1880000 Unitaid Solthis 47566 Unitaid Solthis XM-DAC-30010-Catalytic_LLINs Unitaid Continued reduction in malaria incidence, morbidity and mortality by the establishment of a sustainable market for a broader set of LLIN tools, which perform in areas of pyrethroid resistance, and have the potential to support insecticide-resistance management. IVCC unitaid@who.int 3112967 6367659 2101825 Unitaid IVCC 15000000 INNOVATIVE VECTOR CONTROL CONSORTIUM 2426113 Unitaid IVCC 2375970 Unitaid Innovative Vector Control Consortium 4650000 Unitaid Innovative Vector Control Consortium 16505077 Unitaid Innovative Vector Control 33000000 Grant Agreement Value by Unitaid. Co-funded with additional $33,000,000 by the Global Fund Unitaid IVCC 11549000 Unitaid 5072000 Unitaid Innovative Vector Control Consortium (IVCC) 2923606 UNITAID Innovative Vector Control Consortium (IVCC) XM-DAC-30010-utd-i+sol_a2s2 Unitaid The project supports the production of additional Artemisia (40 MT) to contribute to stabilizing the price of artemisinin, the key ingredient in artemisinin combination therapy (ACT). The project provides loans to artemisinin extractors through tri-partite agreements between an artemisinin extractor, a prequalified ACT manufacturer and i+solutions i+solutions UNITAID July 2009 End of 2013 UNITAID Ambachew Yohannes 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 9280400 i+solutions 9280400 i+solutions -4999992 i+solutions -1480180 i+solutions -1200000 i+solutions XM-DAC-30010-utd-zyomyx_poc Unitaid The overall goal of this project is the uptake of the Zyomyx CD4 test in 12 low and middle income countries. The Grantee shall seek to achieve successful field evaluations of the test, together with regulatory approvals, the scale up of manufacturing capacity and distribution of the test, in accordance with the commercialization and access Zyomyx UNITAID December 2013 Middle of 2014 UNITAID Danielle Ferris 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 1610887 Unitaid Zyomyx 7534000 Unitaid Zyomyx XM-DAC-30010-utd-gfatm_r6 Unitaid This project aims to scale up access to treatment and to improve affordability of medicines for AIDS, MDR-TB and malaria through Global Fund grants in Round 6, Phase 1 for 42 grants in 37 countries Global Fund to Fight AIDS, Tuberculosis and Malaria UNITAID December 2007 End of 2011 UNITAID Robert Matiru 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 27721132 Unitaid Global Fund to Fight AIDS, Tuberculosis and Malaria -10970824 Unitaid Global Fund to Fight AIDS, Tuberculosis and Malaria 38691956 Global Fund to Fight AIDS, Tuberculosis and Malaria XM-DAC-30010-utd-pmtct_nutr Unitaid Nutritional care linked to PMTCT in 4 of the PMTCT 1 countries (mid-2009-mid-2011). Malawi, Rwanda, Tanzania, Zambia. UNICEF UNITAID July 2009 End of 2011 UNITAID Robert Matiru 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 2291284 UNICEF 675441 UNICEF 4510847 Unitaid UNICEF 2219563 Unitaid UNICEF 18507 Unitaid UNICEF XM-DAC-30010-utd-gdf_pedstb Unitaid This project has provided 750,000 paediatric treatments to 57 countries and aims to foster the development of child-friendly formulations of TB treatments for children under-5 years of age STOP TB UNITAID January 2007 End of 2013 UNITAID Robert Matiru 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 4078080 Unitaid STOP TB 1517018 Unitaid STOP TB 1517015 Unitaid STOP TB 5834950 STOP TB 889920 Unitaid STOP TB 5792111 Unitaid STOP TB 1713920 Unitaid STOP TB 4945030 Unitaid STOP TB XM-DAC-30010-utd-pmtct_init Unitaid UNICEF UNITAID December 2007 End of 2011 UNITAID Robert Matiru 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 20838432 Unitaid UNICEF 7262247 Unitaid UNICEF -3171559 Unitaid UNICEF -401962 Unitaid UNICEF 6540478 Unitaid UNICEF 7100464 Unitaid UNICEF 26763660 Unitaid UNICEF -1071232 Unitaid UNICEF -5961408 Unitaid UNICEF 26763660 Unitaid UNICEF XM-DAC-30010-utd-pmtct_exp Unitaid Expansion of PMTCT 1 to 9 additional countries (mid-2009-mid-2011). Central African Republic, China, Haiti, Lesotho, Myanmar, Nigeria, Swaziland, Uganda, Zimbabwe UNICEF UNITAID July 2009 End of 2011 UNITAID Robert Matiru 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 46679993 Unitaid UNICEF 28446003 Unitaid UNICEF -1615250 Unitaid UNICEF 18233990 Unitaid UNICEF -8666645 Unitaid UNICEF XM-DAC-30010-utd-gdf_mdrsc Unitaid The aim of this joint Project (otherwise known as the MDR-TB Scale-up Initiative) is to scale-up access to quality assured anti-TB drugs to treat MDR-TB patients in eligible countries and positively impact the dynamics of the MDR-TB drug market STOP TB UNITAID July 2007 End of 2013 UNITAID Robert Matiru 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 21444600 STOP TB 9795611 Unitaid STOP TB 5113950 Unitaid STOP TB 14420000 Unitaid STOP TB 7302700 Unitaid STOP TB 17347260 Unitaid STOP TB 14579715 Unitaid STOP TB 12305410 Unitaid STOP TB 2111500 Unitaid STOP TB 2320140 Unitaid STOP TB XM-DAC-30010-utd-gdf_mdrsrs Unitaid This project intends to increase the number of patients accessing quality 2nd line anti-TB medicines by improving price, number and quality of products and facilitating faster delivery lead times through a strategic rotating stockpile STOP TB UNITAID Middle of 2015 November 2008 UNITAID Robert Matiru 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 9872862 Unitaid STOP TB 14097545 Unitaid STOP TB 12478000 Unitaid STOP TB 14890675 Unitaid STOP TB 2295805 Unitaid STOP TB XM-DAC-30010-utd-unicef_llin Unitaid LLINs delivered to country, either held in port awaiting release or awaiting distribution as of 28 August 2009 (from 1st interim report of UNICEF to UNITAID, 31 August 2009) UNICEF UNITAID February 2009 End of 2010 UNITAID Ambachew Yohannes 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 109246140 Unitaid UNICEF 109246140 Unitaid UNICEF -43716 UNICEF Unitaid -8408424 UNICEF Unitaid XM-DAC-30010-utd-gdf_1ltb Unitaid The project provides first line TB medicines through transitional grants to minimize the risk of stock outs and therefore drug resistance among patients in countries that will face a gap in drug supply between the end of a GDF grant and the start of a planned future source of funding for first line anti-TB medicines STOP TB UNITAID September 2007 End of 2011 UNITAID Robert Matiru 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 27645947 Unitaid STOP TB 4514181 Unitaid STOP TB 23131766 Unitaid STOP TB -8434739 STOP TB Unitaid XM-DAC-30010-utd-daktari_poc Unitaid The projectc aims to support the introduction of a novel point-of-care CD4 diagnostic to the market in sub-Saharan Africa, Latin America, and South-east Asia at affordable prices.  This will be done through clinical validation of the Daktari CD4 system; enhancing manufacturing capacity development; and conducting operational studies for regulatory approval. (The product is a battery-powered, point-of-care CD4 testing system, which will provide a CD4 cell count result in less than 12 minutes from a finger stick of blood) Daktari UNITAID End of 2016 December 2013 UNITAID Danielle Ferris 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 2687000 Unitaid Daktari -608741 Unitaid Daktari 1208252 Unitaid Daktari XM-DAC-30010-utd-estheraid Unitaid This project contributes to improving supply chain management from national central medical stores to treatment centres in 5 West African countries  by improving logistic information systems and patient monitoring systems. The project also supports the efforts of treatment centres to improve treatment choices by making sure that UNITAID supplied tests and treatments are received and used ESTHER UNITAID July 2009 End of 2014 UNITAID Jane Galvao 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 451626 Unitaid ESTHER 14229362 Unitaid ESTHER 2385093 Unitaid ESTHER 451626 Unitaid ESTHER 4041370 Unitaid ESTHER 503979 Unitaid ESTHER 2617801 Unitaid ESTHER 1556114 Unitaid ESTHER 680272 Unitaid ESTHER 995207 Unitaid ESTHER 877414 Unitaid ESTHER XM-DAC-30010-utd-pfscm_cpp Unitaid The project aims to establish a common framework for understanding stock out risks, improving funding coordination and procurement and supply management of medicines for HIV/AIDS, TB and malaria. The financial contribution of UNITAID is to develop a publically accessible database and web-platform to improve information sharing between the CPP Members and to be more effective in preventing stock outs. Six countries are included in the initial phase of the project: Angola, Burkina Faso, Cameroon, Central African Republic, Mali, and Mozambique PFSCM UNITAID August 2012 End of 2013 UNITAID Robert Matiru 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 127000 Unitaid PFSCM 190144 Unitaid PFSCM 63144 Unitaid PFSCM XM-DAC-30010-utd-cepheid Unitaid The Cepheid Buy-Down agreement reduced the cost of Xpert MTB/RIF cartridges for GeneXpert, a new highly accurate, rapid diagnostic test for TB from $16.86 to $9.98, a price which will not increase until 2022. The effective date of this price decrease is August 6, 2012. Cepheid UNITAID End of 2022 December 2012 UNITAID Robert Matiru 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 4100000 Unitaid Cepheid 3200000 Unitaid Cepheid XM-DAC-30010-utd-chai_poc1 Unitaid The project intends to prepare the market for accelerated scale-up of POC HIV Dx: CD4, VL and EID by working with 7 high-volume early adopter countries to prepare for rapid scale-up of POC Dx, while helping new suppliers through the regulatory and policy approval processes CHAI UNICEF UNITAID November 2012 Middle of 2014 UNITAID Robert Matiru 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 3550000 Unitaid CHAI 1054740 Unitaid CHAI 10998000 Unitaid UNICEF 358402 Unitaid CHAI 19641598 Unitaid CHAI 583000 Unitaid UNICEF 2100000 Unitaid CHAI 1848456 Unitaid CHAI XM-DAC-30010-utd-act_lib&bur Unitaid This project intends to support the delivery of ACT treatments for malaria for Burundi and Liberia on an exceptional, emergency basis to prevent stock outs of these medicines during the malaria season in these countries. UNITAID resources will be used to finance the purchase of ACT treatments only UNICEF World Health Organisation - assessed contributions UNITAID March 2007 End of 2007 UNITAID Ambachew Yohannes 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 1348002 Unitaid World Health Organisation - assessed contributions -370253 Unitaid World Health Organisation - assessed contributions XM-DAC-30010-utd-act_scaleup Unitaid The ACT Scale-up project was initiated to provide 47,016,160 high quality ACT treatments to seven countries. The project covers 11 programs chosen because of their participation in the GFATM round grants UNICEF Global Fund to Fight AIDS, Tuberculosis and Malaria UNITAID December 2007 End of 2012 UNITAID Ambachew Yohannes 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 15757185 Unitaid UNICEF 65413057 Unitaid UNICEF 9128683 Unitaid UNICEF 4644698 Unitaid UNICEF 7083306 Unitaid UNICEF 3230260 Unitaid UNICEF -559455 Unitaid UNICEF XM-DAC-30010-utd-expand_tb Unitaid The project accelerates access to MDR TB diagnosis by introducing new and rapid technologies and laboratory service together with the necessary know-how for technology transfer. The intention is to identify an estimated 115,000 MDR TB patients in 27 countries to enable appropriate treatment of these patients STOP TB World Health Organisation - assessed contributions FIND UNITAID End of 2014 December 2008 UNITAID Robert Matiru 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 4015867 STOP TB 4224300 STOP TB 9043400 STOP TB 11330000 STOP TB 49378718 World Health Organisation - assessed contributions 11747364 STOP TB 18228934 STOP TB 5087857 STOP TB 1530000 STOP TB 9352395 STOP TB 21003040 World Health Organisation - assessed contributions 2780645 FIND 7074955 STOP TB 5738611 FIND 13491631 FIND 1196758 STOP TB XM-DAC-30010-utd-chai_peds Unitaid The goal of the Project is to maintain on-going access to paediatric ARVs, diagnostic bundles and related components. The project is also increasing the sustainability of the paediatric marketplace through the use of supplier selection techniques that increase the number of quality assured paediatric products and reduce their prices. The project is also working to identify long-term funding sources for paediatric ARVs and related commodities and support countries in securing these funds CHAI UNITAID November 2006 End of 2014 UNITAID Jane Galvao 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 6313760 CHAI 9100000 CHAI 57930000 CHAI 13180500 CHAI 24497113 CHAI 37779000 CHAI 13887500 CHAI 28000000 CHAI 9500000 CHAI 10943000 CHAI 12000000 CHAI 10000000 CHAI 14633000 CHAI 62800350 CHAI 8123250 CHAI 11000000 CHAI 4240000 CHAI 1860000 CHAI 30417000 CHAI 9191000 CHAI 26800000 CHAI 63730202 CHAI 33433635 CHAI 77938806 CHAI 10963000 CHAI 30445000 CHAI 80383638 CHAI 23052000 CHAI 8000000 CHAI 5299000 CHAI 14776000 CHAI 1824250 CHAI XM-DAC-30010-utd-chai_2larv Unitaid The objective of the Second-Line Project is to ensure on-going access to second-line ARVs through the use of supplier selection techniques that increase the number of quality assured second-line products and reduce their prices CHAI UNITAID March 2007 End of 2012 UNITAID Jane Galvao 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 16443000 CHAI 35900000 CHAI 19995500 CHAI 73403000 CHAI 31298137 CHAI 37995000 CHAI 21348149 CHAI 6600000 CHAI 8926000 CHAI 47515557 CHAI 18926752 CHAI 64330000 CHAI 78502000 CHAI 33124206 CHAI 28000000 CHAI 5695000 CHAI 7000000 CHAI 1761200 CHAI 15393200 CHAI 832200 CHAI 2124000 CHAI XM-DAC-30010-utd-gfatm_amfm Unitaid The AMFm objective is to significantly reduce the price for ACT treatments paid by end-users through a subsidy mechanism to the private sector. This is essential to increase access to effective malaria treatment and to delay the development of resistance to artemisinin. AMFm is currently implemented through nine programs in eight countries: Cambodia, Ghana, Kenya, Madagascar, Niger, Nigeria, Tanzania and Uganda Global Fund to Fight AIDS, Tuberculosis and Malaria UNITAID November 2009 End of 2013 UNITAID John Cutler 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 65000000 Global Fund to Fight AIDS, Tuberculosis and Malaria 65000000 Global Fund to Fight AIDS, Tuberculosis and Malaria 25000000 Global Fund to Fight AIDS, Tuberculosis and Malaria 30970824 Global Fund to Fight AIDS, Tuberculosis and Malaria 130000000 Global Fund to Fight AIDS, Tuberculosis and Malaria 25000000 Global Fund to Fight AIDS, Tuberculosis and Malaria 50000000 Global Fund to Fight AIDS, Tuberculosis and Malaria 10970824 Global Fund to Fight AIDS, Tuberculosis and Malaria 20000000 Global Fund to Fight AIDS, Tuberculosis and Malaria XM-DAC-30010-utd-burnet_poc Unitaid The purpose of the project is to catalyse global market access to CD4 testing in developing countries burdened with HIV, through the use of an appropriate low cost, instrument free, point of care CD4 test.  It is expected that this will increase the rate of ART initiation and retention of patients in health care. The project focuses on interventions to achieve successful field evaluations of the Test, together with regulatory approvals, the scale-up of manufacturing capacity, distribution and availability of the Test in low and middle income countries The Burnet Institute UNITAID End of 2016 December 2013 UNITAID Danielle Ferris 41227915503 unitaid@who.int Avenue Appia 20 CH-1211 Geneva 27 Switzerland 1626696 The Burnet Institute 33300 The Burnet Institute 931948 The Burnet Institute 113630 The Burnet Institute XM-DAC-30010-TIMCI_PATH Unitaid The grant aims to improve the detection of severe disease in children under five, including newborns, by equipping primary health care workers with pulse oximeters and decision support tools to enhance their ability to diagnose severe disease. Also, it will accelerate the development and market entry of non-invasive devices that augment the features of standard pulse oximeters with one or more additional vital sign measurements. PATH Unitaid Operations Charlotte Kristansson Programme Manager 41227911200 kristianssonc@unitaid.who.int https://unitaid.org/ Unitaid – Global Health Campus, Chemin du Pommier 40, 5th floor, 1218 Grand-Saconnex Geneva, Switzerland 1235934 5617178 8726028 9790019 8304864 1711363 3500000 Unitaid PATH 1651472 Unitaid Tools for Integrated Management of Childhood Illness (TIMCI) 786000 Unitaid PATH 1094000 Unitaid PATH 3662031 Unitaid PATH 6950000 Unitaid PATH 139156 Unitaid PATH 36518370 Grant Agreement Value. Value of the grant was increased by $1,713,794, after amendment due to Covid 19 Unitaid PATH 5467000 Unitaid PATH 1508130 Unitaid Program for Appropriate Technology in Health (PATH) 1371000 Unitaid PATH 1453609 Unitaid Partners in Health 634786 Unitaid Program for Appropriate Technology in Health 174582 Unitaid UNICEF 6630000 Unitaid PATH XM-DAC-30010-CIFA Unitaid COVID innovations for all: Enhancing solidarity to ensure medical innovations for COVID-19 benefit all Wemos Foundation Unitaid ELEVELD Jan Akko Programme Manager 41227911200 https://unitaid.org/#en 506218 927965 259285 558000 Unitaid WEMOS 747281 Unitaid Stichting Wemos 996402 UNITAID STICHTING WEMOS 139067 Unitaid Stichting Wemos 1693469 Unitaid Wemos XM-DAC-30010-ACT-A Unitaid FOR FINANCING THE PROCUREMENT OF HEALTH PRODUCTS IN SUPPORT OF THE ‘ACCESS TO COVID-19 TOOLS ACCELERATOR’ (ACT-A) UNICEF 4122791200 ryant@who.int https://unitaid.org/about-us/#en 4000000 4000000 Unitaid UNICEF XM-DAC-30010-WHE-1 Unitaid WHE Oxygen Technical Assistance & Acute Biomedical Needs Procurement Project World Health Organisation PETZOLDT Marc Programme Manager 41227911200 petzoldtm@unitaid.who.int https://unitaid.org/#en 5000000 5000000 Unitaid World Health Organisation - WHE 5000000 World Health Organisation - WHE XM-DAC-30010-EJAF Unitaid This is a partnership agreement Unitaid is entering with EJAF and CIFF, in which each party contributes to a total budget of USD 6 million. Elton John AIDS Foundation Unitaid Operations Heather Ingold Programme Manager +41 22 791 12 00 unitaid@who.int https://unitaid.org/ Chemin du Pommier 40, 5th floor, 1218 Grand-Saconnex Geneva, Switzerland 500000 500000 500000 1500000 Unitaid Elton John AIDS Foundation 1500000 Unitaid EJAF XM-DAC-30010-MVIP-Phase2 Unitaid Malaria Vaccine Implementation Programme (MVIP) Phase 2 World Health Organization Ambachew Yohannes yohannesam@who.int https://unitaid.org/#en 2529530 1070470 3600000 Unitaid World Health Organization 2529980 Unitaid World Health Organization XM-DAC-30010-WHE-2 Unitaid WHE Oxygen Technical Assistance & Acute Biomedical Needs Procurement Project World Health Organization (WHO) PETZOLDT Marc Programme Manager 41227911200 petzoldtm@unitaid.who.int https://unitaid.org/#en 10000000 10000000 Unitaid World Health Organization 10000000 Unitaid World Health Organization XM-DAC-30010-mRNA-hub Unitaid Norway to fund the MPP’s implementation of the South African mRNA Technology Transfer Hub Project, (“the mRNA Project”) MPP Foundation ELEVELD, Jan Akko Programme Manager eleveldj@who.int https://unitaid.org/#en 4332500 2166250 Unitaid Medicines Patent Pool Foundation 2166250 Unitaid Medicines Patent Pool Foundation XM-DAC-30010-ACT-A-Japanfunds Unitaid Fund the MPP’s work within the Access to COVID-19 Tools Accelerator (“ACT-A”) during 2022. MPP Foundation Fund the MPP’s work within the Access to COVID-19 Tools Accelerator (“ACT-A”) during 2022. Hencher Katerine Team Lead 41227911200 hencherk@unitaid.who.int https://unitaid.org/#en 165000 165000 Unitaid Medicines Patent Pool Foundation XM-DAC-30010-TWN-TRIPS Unitaid ​The goal is to enable generic competition and increase access to affordable HIV, TB and HCV treatments in the Asia-Pacific and Africa regions through the effective use of TRIPS flexibilities. Third World Network Unitaid Jan Akko Eleveld Programme Manager +41 22 791 12 00 unitaid@who.int Unitaid – Global Health Campus, Chemin du Pommier 40, 5th floor, 1218 Grand-Saconnex Geneva, Switzerland 233450 973807 902203 1030722 1451152 1015274 607885 Unitaid Third World Network 1234682 Unitaid Third World Network 705600 Third World Network 338425 Unitaid Third World Network 1000000 Unitaid Third World Network 1030482 Unitaid Third World Network 401705 Unitaid Third World Network 5606608 Grant Agreement Value Third World Network XM-DAC-30010-ITPC-TRIPS Unitaid Aims to address a critical gap in the global HIV response: access to newer, optimized ARVs and direct-acting antivirals (DAAs) for curing HCV. International Treatment Preparedness Coalition (ITPC) Unitaid Jan Akko Eleveld Programme Manager +41 22 791 40 41 unitaid@who.int https://unitaid.org/ 406562 2464069 2409052 2584687 2499878 2653250 1227565 Unitaid International Treatment Preparedness Coalition 865170 Unitaid International Treatment Preparedness Coalition (ITPC) Global NPC 1024127 Unitaid International Treatment Preparedness Coalition Global NPC 1539085 Unitaid International Treatment Preparedness Coalition (ITPC) Global NPC 13084445 Grant Agreement Value Unitaid International Treatment Preparedness Coalition (ITPC) 1550744 Unitaid International Treatment Preparedness Coalition (ITPC) Global NPC 1147875 Unitaid International Treatment Preparedness Coalition (ITPC) 1085564 Unitaid ITPC 1500000 INTERNATIONAL TREATMENT PREPAREDNESS COALITION GLOBAL NPC 2131271 Unitaid International Treatment Preparedness Coalition 1000000 Unitaid International Treatment Preparedness Coalition (ITPC) XM-DAC-30010-UnitaidExplore Unitaid Unitaid Explore EPFL Kristiansson Charlotte Programme Manager, team lead 41227911200 kristianssonc@who.int https://unitaid.org/#en 238550 423556 935144 587417 Unitaid The École Polytechnique Fédérale de Lausanne (EPFL) 100000 Unitaid The École Polytechnique Fédérale de Lausanne (“EPFL”) 1597251 Unitaid EPFL - École Polytechnique Fédérale de Lausanne 193568 Unitaid EPFL 44982 Unitaid EPFL - École Polytechnique Fédérale de Lausanne 423556 Unitaid The École Polytechnique Fédérale de Lausanne 247727 Unitaid École Polytechnique Fédérale de Lausanne - EPFL XM-DAC-30010-AIRE_ALIMA Unitaid The grant aims to increase effective referrals from primary health care to district hospitals, in the West-African context, where appropriate care should be available to improve child survival. This will be achieved by increasing access and use of pulse oximeters at the primary health care level.. The AIRE project will conduct an operational research focused on creating a proof of concept for the use of pulse oximeters in primary health facilities) ALIMA Unitaid Operations Ana Alvarez Nieto Programme Manager +41 22 791 12 00 unitaid@who.int https://unitaid.org/ Unitaid – Global Health Campus, Chemin du Pommier 40, 5th floor, 1218 Grand-Saconnex Geneva, Switzerland 505868 4990499 7041966 8097684 2105531 1733000 Unitaid The Alliance for International Medical Action - ALIMA 900000 Unitaid The Alliance for International Medical Action (ALIMA) 1809950 Unitaid The Alliance for International Medical Action (ALIMA) 4500000 Unitaid THE ALLIANCE FOR INTERNATIONAL MEDICAL ACTION - ALIMA 3617000 Unitaid Alliance for International Medical Action (ALIMA) 23450271 Grant Agreement Value Unitaid ALIMA (The Alliance for International Medical Action) 2536658 Unitaid The Alliance for International Medical Action (ALIMA) 2036450 Unitaid ALIMA 3200000 Unitaid ALIMA 3000000 Unitaid The Alliance for International Medical Action (ALIMA) XM-DAC-30010-utd-psi_star Unitaid The goal of the project is to increase the percentage of the target population who know their HIV status. The direct outcome of this project will be increased effective use of HIVOFT for self-testing among target populations in the three target countries of Malawi, Zambia, and Zimbabwe. The project will simultaneously develop an evidence base for public health policy makers in order to inform the development of the World Health Organization’s normative guidance on HIVST and appropriate country-level policies and demonstrate a viable market for HIVST, using HIVOFT or FSB RDTs Population Service International (PSI) World Health Organization Society for Family Health UNITAID Covers Phase I and Phase II of the project UNITAID Heather Ingold Programme Manager +41 22 791 12 00 ingoldh@unitaid.who.int Chemin de Blandonnet 10 – BIBC III – 8th Floor 1214 Vernier, Switzerland 3743621 11986888 9175001 5778709 10642061 8915660 12984939 1618322 893000 Unitaid Population Services International (PSI) 4414000 Unitaid 19163958 Phase II Unitaid Population Services International 7040000 Unitaid Population Services International 5538000 Unitaid Population Services international 4000000 Unitaid Society for Family Health 3049000 Unitaid PSI 458000 Population Service International 5545000 Unitaid Population Services International 1828413 Unitaid Society for Family Health 1925000 Unitaid Society for Family Health 9143695 Unitaid Population Services International 7144000 Unitaid Population Service International 1930000 Unitaid Population Services International (PSI) 1500000 Unitaid Population Service International 23660993 Grant Agreement Value for Phase I of the project Unitaid Population Service International 208000 Unitaid World Health Organization 5000000 Unitaid Population Services International 135675 Funds returned to Unitaid Population Services International Unitaid 9965000 Disbursement for Phase 2 of the project Unitaid Population Service International 591000 Unitaid Population Services International 19163958 Grant Agreement Value, for SFH Unitaid Population Service International 7880000 Unitaid Population Services International 4860000 Disbursement under Phase 2 of the project Unitaid The Society for Family Health (SFH) 4161000 Unitaid Society for Family Health 2257000 Unitaid Society for Family Health 7481630 Unitaid Population Services International 1161025 Unitaid Society for Family Health 1361000 Unitaid Population Services International XM-DAC-30010-FIND_DriveDx4TB Unitaid Accelerating tools to drive tuberculosis detection (DriveDx4TB) FIND DE LUSSIGNY Smiljka Programme Manager 41227911200 delussignys@unitaid.who.int https://unitaid.org/#en 551160 5432931 3812212 4529636 794130 15900000 Unitaid Foundation for Innovative New Diagnostics (FIND) 4575000 Unitaid Foundation for Innovative New Diagnostics 2700000 Unitaid Foundation for Innovative New Diagnostics (FIND) 4575000 Unitaid Foundation for Innovative New Diagnostics 4000000 Unitaid Foundation for Innovative New Diagnostics (FIND) 3000000 Unitaid Foundation for Innovative New Diagnostics (FIND) XM-DAC-30010-UND Unitaid The University of Notre Dame’s project–Advancing Spatial Repellents for Vector-borne Disease Control–will evaluate slow-release spatial repellents that can be easily deployed in houses and temporary shelters. The repellants are delivered via small, clear plastic sheets hung in strategic spots. University of Notre Dame Unitaid Operations Ekaterina Rykovanova Programme Manager +41 22 791 12 00 unitaid@who.int https://unitaid.org/ Unitaid – Global Health Campus, Chemin du Pommier 40, 5th floor, 1218 Grand-Saconnex Geneva, Switzerland 1285199 4106591 4950074 6188053 7793578 8165627 2198014 5146801 Unitaid University of Notre Dame du Lac 2387815 Unitaid University of Notre Dame 1767000 Unitaid University of Notre Dame 33724865 Grant Agreement Value Unitaid University of Notre Dame 1494767 Unitaid University of Notre Dame 5438887 Unitaid University of Notre Dame 5645000 Unitaid University of Notre Dame 2029535 Unitaid University of Notre Dame 1000000 Unitaid University of Notre Dame du Lac 2956109 Unitaid University of Notre Dame 4218280 Unitaid University of Notre Dame Project page XM-DAC-30010-Anticov Unitaid Clinical trial and protocol implementation preceded by ANTICOV phase 1 Drugs for Neglected Diseases initiative (DNDi) RYKOVANOVA Ekaterina Project Manager 41227911200 rykovanovae@unitaid.who.int https://unitaid.org/#en 1823582 5487491 7131935 1598348 Unitaid Drugs for Neglected Diseases initiative 2800000 Unitaid Drugs for Neglected Diseases initiative 14698838 Unitaid Drugs for Neglected Diseases initiative 1250337 Unitaid DRUGS FOR NEGLECTED DISEASES INITIATIVE (DNDI) 5063538 Unitaid DRUGS FOR NEGLECTED DISEASES INITIATIVE (DNDI) 3969257 Unitaid DRUGS FOR NEGLECTED DISEASES INITIATIVE (DNDI) XM-DAC-30010-TBSPEED Unitaid The goal is to contribute to the reduction in childhood mortality from tuberculosis by delivering an available, feasible, cost-effective, and decentralized childhood tuberculosis diagnostic approach to enhance case-finding and access to treatment. Universite de Bordeaux Unitaid Yamuna Mundade Programme Manager +41 22 791 12 00 mundadey@who.int https://unitaid.eu Chemin de Blandonnet 10 – BIBC III – 8th Floor 1214 Vernier, Switzerland 1611480 3865030 3675063 2940352 242751 2125030 213656 220067 Unitaid 3585000 14670470 Grant Agreement Value Unitaid 364533 Unitaid Universite de Bordeaux 2135577 Unitaid University of Bordeaux 908238 Unitaid Universite de Bordeaux 1731000 Unitaid Universite de Bordeaux 3510161 Unitaid Universite de Bordeaux 2028033 Unitaid Universite de Bordeaux XM-DAC-30010-OptimalARVs Unitaid The Goal of this project is to contribute to the scale-up of Optimal ARVs at the global level. Clinton Health Access Initiative Unitaid Danielle Ferris Programme Officer ferrisd@unitaid.who.int 7499912 10001378 9221864 13570608 17483570 11356427 1714144 9000000 Unitaid Clinton Health Access Initiative (CHAI) 4300000 Unitaid CLINTON HEALTH ACCESS INITIATIVE, INC. 1691688 Unitaid Clinton Health Access Initiative 5540000 Unitaid CHAI 4700714 6229428 Unitaid Clinton Health Access Initiative 4289712 Unitaid Clinton Health Access Initiative 5703500 Unitaid Clinton Health Access Initiative 4224000 3713543 Unitaid Clinton Health Access Initiative 5814130 Unitaid CHAI 5000000 Unitaid CHAI 1608063 Unitaid Unitaid Clinton Health Access Initiative 70847904 Amended Grant Agreement Value (after grant reprogramming in 2019) Unitaid CHAI 2085737 UNITAID CHAI 5738239 Unitaid Clinton Health Access Inititiave XM-DAC-30010-UTDExplore Unitaid To accelerate the development, regulatory approval and commercialisation of an innovative taste-masked paediatric fixed-dose combination of artesunate/amodiaquine for the treatment of paediatric malaria based on the Recipient’s MicroCoat technology for use in low-resource settings Fluid Pharma Blumer Katherine Programme Manager 41227911200 blumerk@who.int https://unitaid.org/#en 1076978 1076978 809925 1886903 Unitaid Fluid Pharma 557125 Unitaid Fluid Pharma 648283 Unitaid Fluid Pharma 55962 Unitaid Fluid Pharma 519853 Unitaid Fluid Pharma 105681 Unitaid Fluid Pharma XM-DAC-30010-IMPACT Unitaid ​The IMPACT project will develop long-acting injectable ivermectin to fight malaria transmission MEDINCELL Unitaid ELEVELD Jan Akko https://unitaid.org 787630 1255794 2113349 2003009 3000000 3000000 2920000 Unitaid Medincell 486556 Unitaid Medincell 500110 Unitaid Medincell 754085 Unitaid 305000 Unitaid Medincell 400111 Unitaid Medincell 12338828 Unitaid MedinCell 1115044 Unitaid MedinCell SA 800752 Unitaid MedinCell XM-DAC-30010-D2EFT Unitaid The project goal is to contribute to scale-up of improved second-line ARV treatment. UNIVERSITY OF NEW SOUTH WALES – KIRBY INSTITUTE Unitaid Danielle Ferris Programme Manager ferrisd@unitaid.who.int 1184030 1419460 1903740 2089181 1641921 2080821 1045804 Unitaid University of New South Wales 1033439 Unitaid University of New South Wales 1901833 1338471 Unitaid The University of New South Wales 219232 Unitaid University of New South Wales on behalf of the Kirby Institute 1344743 Unitaid The University of New South Wales 710000 Unitaid University of New South Wales 119412 Unitaid University of New South Wales ( 1360678 Unitaid University of New South Wales on behalf of the Kirby Institute 225000 Unitaid University of New South Wales 663840 Unitaid University of New South Wales 10319152 Grant Agreement Value. Value of the grant was increased by $219,232 after amendment due to Covid 19 XM-DAC-30010-MMVSupplyGrant Unitaid The overarching goal of the MMV Supply Grant is to increase access to malaria chemoprevention and severe malaria commodities. The outcome of the project is to improve increased availability and supply of quality assured malaria chemoprevention and severe malaria products. Medicines for Malaria Venture 459103 705882 831630 580950 966590 1030667 205514 1001096 Unitaid Medicines for Malaria Venture 82859 Unitaid Medicines for Malaria Venture 773552 Unitaid Medicines for Malaria Venture 974516 Unitaid Medicines for Malaria Venture 4780336 Grant Agreement Value 1279691 Unitaid Malaria Medicines Venture (MMV) 630222 Unitaid Malaria Medicine Venture XM-DAC-30010-SC-TRIPS Unitaid To provide government policymakers and CSOs in LMIC with, a service on how to use TRIPS flexibilities, training, global fora on TRIPS flexibility and educational visits, research and publication and guides. South Center unitaid@who.int 712280 1916623 1643893 1239778 1584446 1126949 1047810 Unitaid South Centre 347705 Unitaid The South Centre 597652 Unitaid South Centre 8223969 Grant Agreement Value Unitaid South Center 48510 Unitaid The South Centre 1992968 Unitaid South Centre 124601 Unitaid South Centre 981845 Unitaid South Center 1220686 Unitaid South Center 627374 Unitaid South Centre 71016 Unitaid South Centre 1163802 Unitaid South Centre XM-DAC-30010-utd-pih_endtb Unitaid EndTB aims to radically change the MDR-TB (multidrug resistant tuberculosis) market by accelerating uptake of the newly released MDRTB drugs (bedaquiline and delamanid) in 16 countries. The intervention will have long-term market effects that will consolidate the market for MDR-TB drugs, expanding access to new, effective, and user-friendly treatment regimens for patients with MDR-TB Partners in Health UNITAID Grant was extended from 2019 till 2022 UNITAID Ekaterina Rykovanova Programme Manager rykovanovae@who.int 28202016 29016716 23919146 4150990 6000000 Unitaid Partners in Health 11457990 2000000 Unitaid Partners in Health (PIH) 3300000 Unitaid Partners in Health 2500000 Unitaid Partners in Health 3000000 Unitaid Partners in Health 4270000 Unitaid Partners in Health 4289484 Unitaid Partners in Health 2860346 Unitaid Partners in Health (PIH) 3935633 Unitaid Partners in Health 150000 Unitaid Partners in Health 500000 Unitaid Partners in Health 2000000 Unitaid Partners in Health 1815956 Unitaid Partners in Health - PIH 2300000 Unitaid Partners in Health 894152 Unitaid Partners in Health - PIH 147340 Unitaid Partners in Health 4250000 Unitaid Partners in Health 5000000 Unitaid Partners in Health 892179 Unitaid Partners in Health 1174771 Unitaid Partners in Health 6344004 Unitaid Partners in Health 3095678 Unitaid Partners in Health 9538000 Partners in Health 8556273 85288868 The value of the grant was increased from $60 Million to $81 Million in 2018, after Unitaid Executive Board approved grant duration extension (till 2022) and expansion. Partners in Health 1420287 Unitaid Partners in Health XM-DAC-30010-FINDHCV Unitaid The project aims to contribute to the WHO targets on HCV for 2030: 90% reduction in incidence /65% reduction in mortality / 80% treatment coverage by changing global normative guidelines and national policies driven by FIND Project that are conclusive to scaling up HCV management. The Foundation for Innovative New Diagnostics (FIND) Unitaid Smiljka de Lussigny Programme Manager delussignys@unitaid.who.int 13660596 8557068 675697 1988000 Unitaid FIND Diagnostics 3245000 Unitaid FIND 25257 Unitaid Foundation for Innovative New Diagnostics (FIND) 38264301 Grant Agreement Value 5700000 6192000 Unitaid FIND 3283648 Unitaid FIND - Foundation for Innovative New Diagnostics 501404 UNITAID Foundation for Innovative New Diagnostics (FIND) 1620032 Unitaid Foundation for Innovative New Diagnostics (FIND) 4379000 Unitaid Foundation for Innovative New Diagnostics (FIND) XM-DAC-30010-CAP-TB Unitaid The main expected impact (Goal) of this project is to reduce morbidity and mortality associated with pediatric TB. Elizabeth Glazer Paediatric AIDS Foundation Unitaid Yamuna Mundade Programme Manager +41 22 791 12 00 mundadey@who.int https://unitaid.eu Chemin de Blandonnet 10 – BIBC III – 8th Floor 1214 Vernier, Switzerland 153023 6077659 9273440 10618008 6955806 10268598 2682316 Unitaid Elizabeh Glaser Pediatrics Aids Foundation 3475614 Unitaid Elizabeth Glazer Paediatric AIDS Foundation - EGPAF 877150 Unitaid Elizabeth Glazer Paediatric AIDS Foundation - EGPAF 5000000 Unitaid Elizabeth Glaser Pediatric AIDS Foundation 6819306 Unitaid ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION (EGPAF) 556039 Unitaid EGPAF 4333000 Unitaid EGPAF 6694279 Unitaid Elizabeth Glaser Paediatric AIDS Foundation (EGPAF) 632429 Unitaid EGPAF 7000000 Unitaid Elizabeth Glazer Foundation - EGPAF 7344519 Unitaid Elizabeth Glaser Foundation 36002022 Grant Agreement Value Unitaid Elizabeth Glaser Pediatric AIDS Foundation 2160000 Unitaid Elizabeth Glaser Pediatric AIDS Foundation 3000000 Unitaid Elizabeth Glaser Pediatric AIDS Foundation 4326000 Unitaid Elizabeth Glaser Pediatric AIDS Foundation XM-DAC-30010-utd-ivcc-vctools Unitaid The project aims to increase use of third generation IRS (3GIRS) products in Insecticide Resistance Management Programmes IVCC UNITAID Beginning of 2020 January 2016 UNITAID Ambachew Yohannes yohannesam@unitaid.who.int 18764200 10381071 583053 Unitaid Innovative Vector Control Consortium (IVCC) 10410048 Unitaid IVCC 4371200 Unitaid IVCC 2162459 Unitaid Innovative Vector Control Consortium (IVCC) 8058000 Unitaid IVCC 65105000 IVCC 9692669 3744000 6406105 Unitaid Innovative Vector Control Consortium (IVCC) 5605000 Unitaid IVCC XM-DAC-30010-IMPAACT4TB Unitaid The goal is to reduce TB incidence and deaths among PLHIV (15-49) and child contacts<5 living in low and middle income countries by contributing to the sustainable scale up of affordable, quality-assured 3HP. The Aurum Institute NPC THE PAN AMERICAN HEALTH ORGANIZATION Unitaid Ngwira Chikosa Programme Manager 41227911200 rykovanovae@who.int https://unitaid.eu Chemin de Blandonnet 10 – BIBC III – 8th Floor 1214 Vernier, Switzerland 1143570 3981711 9758177 10825618 16046683 18411020 11066869 9131213 5061157 2061267 Unitaid The Aurum Institute 4615441 Unitaid The Aurum Institute 7000000 Unitaid The Aurum Institute 9000000 Unitaid The Aurum Institute 4000000 Unitaid The Aurum Institute NPC 5000000 Unitaid The Aurum Institute 5645000 Unitaid The Aurum Institute NPC 9000000 Unitaid The Aurum Institute NPC 5000000 Unitaid The Aurum Institute NPC 5000000 Unitaid The Aurum Institute NPC 4500000 Unitaid The Aurum Institute NPC 367956 Unitaid The Aurum Institute NPC 100 Unitaid The Pan Americana Health Organization 2215931 Unitaid The Aurum Institute 5000000 Unitaid The Aurum Institute 2856119 Unitaid The Aurum Institute 1605636 Unitaid The Aurum Institute 6827813 Unitaid The Aurum Institute 3430858 Unitaid The Aurum Institute 141071 Unitaid The Pan Americana Health Organization 2397584 Unitaid Aurum Institute 928000 Unitaid The Aurum Institute 99840 Unitaid 86395159 Grant Agreement Value Unitaid The Aurum Institute XM-DAC-30010-UTDExplore_Delsitech Unitaid The purpose of the Project is to accelerate the development, regulatory approval and UnitaidExplore – Funding Agreement (DelSi Tech)2commercialisation of a long-acting injectable paediatric formulation based on the Recipient’s Silica Matrix technology for use in low-resource settings (the “Health Product”). DELSITECH BLUMER Katherine Programme Manager 0041227911200 blumerk@who.int https://unitaid.org/ 150000 150000 1102600 1020000 116320 Unitaid Delsitech 521000 Unitaid Delsitech 2272600 Unitaid Delsitech 150000 Unitaid Delsitech XM-DAC-30010-Oxygen Unitaid The Oxygen sub-Grant will serve as an enabling investment to the “East Africa Program on Oxygen Access (EAPOA)” grant, implemented by CHAI, World Health Organization (WHO) Jackson Hungu Programme Manager https://unitaid.org/#en 2378034 575944 2999976 Unitaid World Health Organization 2400000 Unitaid World Health Organization 517226 Unitaid World Health Organization 82750 Unitaid World Health organization (WHO) 315394 Unitaid World Health Organization XM-DAC-30010-HEPC3P Unitaid HCV Combination Prevention in PWID and Prisoners Project (HEPC3P) PATH Akko Eleveld Programme Manager 41227911200 eleveldj@who.int https://unitaid.org/#en 1235302 5831287 5454811 2854105 12810525 Unitaid PATH 2245258 Unitaid PATH 3432544 Unitaid PATH 3632326 Unitaid PATH XM-DAC-30010-AG-RDT Unitaid Driving equitable access to fit-for-purpose antigen rapid diagnostic tests for COVID-19 The Foundation for Innovative New Diagnostics (FIND) Tarlton Dessie Programme Manager 41227911200 tarltond@who.int https://unitaid.org/#en 7574162 2234446 1971424.5 Unitaid Foundation for Innovative New Diagnostics (FIND) 10000000 Unitaid The Foundation for Innovative New Diagnostics 1752136.7 Unitaid Foundation for Innovative New Diagnostics (FIND) XM-DAC-30010-PPH Unitaid Research to expand access to Heat-Stable Carbetocin for the treatment of Postpartum Haemorrhage World Health Organization (WHO) Katerine Hencher Team Lead 41227911200 hencherk@unitaid.who.int https://unitaid.org/#en 1159028 4073225 3183417 3845456 2388963 55802 14705891 Unitaid World Health Organization - WHO The Pan American Health Organisation - PAHO 1020396 Unitaid World Health organization - WHO 691709 Unitaid World Health Organization - WHO 106700 Unitaid World Health Organization - WHO 1739614 Unitaid World Health Organization - WHO 2865650 Unitaid World Health organization - WHO 2410069 Unitaid World Health Organization XM-DAC-30010-NSG_FIND Unitaid The project aims to facilitate a transformation of the diagnosis and treatment of DR-TB by accelerating the introduction and global adoption of commercial targeted sequencing for affordable, scalable and rapid DST with near-real time networked interpretation and global reporting The Foundation for Innovative New Diagnostics (FIND) The grant was signed in August 2019, with a start date in October 2019 Unitaid Operations DE LUSSIGNY Smiljka Programme Manager unitaid@who.int https://unitaid.org/ Unitaid – Global Health Campus, Chemin du Pommier 40, 5th floor, 1218 Grand-Saconnex Geneva, Switzerland 372035 5032179 3511369 4236069 4272504 4593664 1665733 467000 Unitaid Foundation for Innovative New Diagnostics (FIND) 2000000 Unitaid Foundation for Innovative New Diagnostics (FIND) 2000000 Unitaid Foundation for Innovative New Diagnostic 3000000 Unitaid Foundation for Innovative New Diagnostics (FIND) 635930 Unitaid FIND 2202311 Unitaid Foundation for Innovative New Diagnistics 2000000 Unitaid Foundation for Innovative New Diagnostics (FIND) 23094653 Grant Agreement Value. Grant value was increased by $4,461,217 after amendment due to Covid 19 Unitaid FIND 6229969 Unitaid FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS (FIND) 2162594 Unitaid Foundation for Innovative New Diagnostics (FIND) XM-DAC-30010-Vivaction Unitaid VivAction - MMV Medicines for Malaria Venture (MMV) Unitaid Matthew Black Programme Manager 41227911200 blackm@who.int https://unitaid.org/#en 1890205 3872467 4940143 5707091 6952020 650210 3468930 Unitaid Medicines for Malaria Venture (MMV) 900000 Unitaid Medicines for Malaria Venture 24950980 Unitaid Medicines for Malaria Venture 1366377 Unitaid Medicines for Malaria Venture (MMV) 6131253 Unitaid Medicines for Malaria Venture 6762323 Unitaid Medicines for Malaria Venture 5118261 Unitaid Medicines for Malaria Venture (MMV) XM-DAC-30010-AMPLI-PPHI Unitaid Accelerating Measurable Progress and Leveraging Investments for PPH Impact Jhpiego THEOLEYRE Romane 41227911200 theoleyrer@unitaid.who.int https://unitaid.org/#en 1259180 4647212 4916009 7177376 2077047 18501433 Unitaid Jhpiego Corporation 4038607 Unitaid Jhpiego Corporation 4388813 Unitaid The Johns Hopkins Central Lockbox - JHPIEGO 4551961 Unitaid Johns Hopkins Central Lockbox 2300000 Unitaid Jhpiego Corporation 3831559 Unitaid Jhpiego Corporation XM-DAC-30010-Enablergrant-EVT Unitaid Improve access to better tools for safe pregnancy and birth for women and newborns – EVT World Health Organisation (WHO) Danielle Ferris Programme Manager ferrisd@who.int https://unitaid.org/ 461266 755970 755970 755970 270823 1782765 Unitaid World Health Organization (WHO) 461266 Unitaid World Health Organization (WHO) XM-DAC-30010-VayuExplore Unitaid Late Stage Development and Regulatory Approval of the Vayu bCPAP and Low-Flow Blender Circuit Devices Vayu Global Health Innovations Hungu Jackson Program Manager 41227911200 hunguj@who.int https://unitaid.org/#en 139000 331642 642142 331642 Unitaid Vayu 286142 Unitaid Vayu 139000 Unitaid Vayu Global Health Innovations, LLC 1413487 Vayu Global Health Innovations 300703 Unitaid Vayu Global Health Innovations, LLC 356000 Unitaid Vayu XM-DAC-30010-CHAI-CxCa-X Unitaid Increase access to screen and treat for cervical cancer and STIs Clinton Health Access Initiative DE LUSSIGNY, Smiljka Programme Manager delussignys@unitaid.who.int https://unitaid.org/ 5495594 4415484 782162 10693241 Unitaid Clinton Health Access Initiative, Inc. (CHAI) 5496000 Unitaid Clinton Health Access Initiative, Inc. (CHAI) XM-DAC-30010-GLAD Unitaid Global long-acting drug combination development (GLAD) project: transformation of oral short-acting TLD to long-acting injectable products University of Washington Unitaid Hencher Katherine Programme Manager https://unitaid.org 666237 1179428 626937 1033610 1476424 4075828 37258 1050000 Unitaid University of Washington 9596236 Unitaid University of Washington 505291 Unitaid University of Washington 1150788 Unitaid University of Washington 535229 Unitaid University of Washington 1421613 Unitaid University of Washington 626098 Unitaid University of Washington 597635 Unitaid University of Washington 710806 Unitaid University of Washington 2200000 Unitaid University of Washington XM-DAC-30010-EVT-SAFEStart Unitaid Improve access to better tools for safe pregnancy and birth for women and newborns – EVT PATH Danielle Ferris Programme Manager ferrisd@who.int https://unitaid.org/ 4210853 6204922 5948414 4157038 773694 3128682 Unitaid PATH 21000000 Unitaid PATH 1000000 Unitaid PATH 2850478 Unitaid PATH 1000000 Unitaid PATH XM-DAC-30010-bohemia Unitaid This project focuses on product development for new vector control tools. It will develop strategies to reduce malaria transmission based on ivermectin mass drug administration (MDA) as the first-in-class endectocide to be evaluated for this indication and will work on dissemination and stakeholder engagement activities to create country demand for this vector control tool. In addition, the project will contribute to the evidence base for endectocides as a complement to existing vector control strategies to inform WHO policy. ISGlobal Unitaid Operations Ekaterina Rykovanova Programme Manager +41 22 791 12 00 unitaid@who.int https://unitaid.org/ Unitaid – Global Health Campus, Chemin du Pommier 40, 5th floor, 1218 Grand-Saconnex Geneva, Switzerland 2198317 4546831 5970638 8180100 5586621 3631615 230250 Unitaid Barcelona Institute for Global Health (ISGlobal) 31068679 Grant Agreement Value, the value of the grant was increased by $600,000 after amendment due to Covid 19 Unitaid ISGlobal 1500000 Unitaid ISGlobal 739603 Unitaid Barcelona Institute for Global Health (ISGlobal) 1531334 Unitaid Barcelona Institute for Global Health (ISGlobal) 1520421 Unitaid The Barcelona Institute for Global Health (ISGlobal) 3078667 Unitaid Barcelona Institute for Global Health (ISGlobal) 600000 Unitaid ISGLOBAL 1264228 Unitaid Barcelona Institute for Global Health (ISGLOBAL) 8986790 Unitaid BARCELONA INSTITUTE FOR GLOBAL HEALTH (ISGLOBAL) 3513673 Unitaid Barcelona Institute for Global Health (ISGlobal) 3157202 Unitaid Barcelona Institute for Global Health (ISGlobal) 3069983 Unitaid Barcelona Institute for Global Health (ISGlobal) 1569082 Unitaid Barcelona Institute for Global Health (ISGlobal) XM-DAC-30010-MPP-III Unitaid The aim of the Foundation is to remove market entry barriers for generic ARVs through "pro-public health" voluntary licenses, in as many countries as possible, and to facilitate the development of FDCs and paediatric formulations. MPP Foundation Katherine Hencher Programme Manager 41227911200 hencherk@unitaid.who.int https://unitaid.org/#en 6099532 6279896 7411231 6682692 7310177 34270691 Unitaid Medicines Patent Pool Foundation 5654000 Unitaid Medicines patent pool foundation 1000000 Unitaid Medicines Patent Pool Foundation 8350000 Unitaid Medicines Patent Pool Foundation 7717430 Unitaid Medicines Patent Pool Foundation 2108522 Unitaid The Medicines Patent Pool Foundation 6054000 Unitaid Medicines Patent Pool Foundation 2205737 Unitaid Medicines Patent Pool Foundation - MPP XM-DAC-30010-EAPOA Unitaid Global Health Emergencies: Improve quality of clinical care packages for COVID-19 (health emergencies) Clinton Health Access Initiative Thomas Gradel Programme Manager gradelt@who.int https://unitaid.org/#en 2907103 6210000 Unitaid Clinton Health Access Initiative, Inc (CHAI) 2000000 Unitaid Clinton Health Access Initiative, Inc (CHAI) 22000000 Unitaid Clinton Health Access Initiative, Inc (CHAI) 2900000 Unitaid Clinton Health Access Initiative, Inc (CHAI) XM-DAC-30010-TB-Enabler Unitaid The goal of the WHO TB Enabler grant is to enable and accelerate adoption and uptake of new TB diagnostics, drugs and new regimens in high burden countries. The project will do this by enabling a policy environment that facilitates and accelerates access to innovations within integrated TB management in countries. World Health Organization Unitaid Eva Nathanson Team Lead, Operations +41 22 791 12 00 474082 1653506 2200997 1538969 1947961 2355325 1760265 1413381 1737439 1691415 Unitaid World Health Organization 2233717 UNITAID WHO 60003 AFRO initiative Unitaid World Health Organization - WHO 1429170 Unitaid World Health Organization 1514081 Unitaid WHO 1694468 Unitaid WHO 2152151 Unitaid World Health Organization 16565000 Grant Agreement Value 465000 Unitaid World Health Organization 1415083 2162396 Unitaid WHO 338444 Unitaid World Health Organization (WHO) XM-DAC-30010-PQDxMedsIII Unitaid Unitaid support to WHO prequalification of medicines and in vitro diagnostics, and to the WHO collaborative procedure for registration World Health Organisation (WHO) Unitaid Operations Katherine Hencher Programme Manager +41 22 791 12 00 https://unitaid.org/ Unitaid – Global Health Campus, Chemin du Pommier 40, 5th floor, 1218 Grand-Saconnex Geneva, Switzerland 7529863 5986225 5584769 5311958 3758772 6967464 9798504 1619000 Unitaid World Health Organization 1622500 Unitaid World Health Organization 28500000 Grant Agreement Value Unitaid World Health Organization 5590000 Unitaid World Health Organization 3000000 Unitaid WHO 2869011 Unitaid World Health Organization - WHO 5202000 Unitaid World Health Organization - WHO 4530000 Unitaid WHO 4584000 Unitaid World Health Organization ( 6400000 Unitaid World Health Organization 10585438 Unitaid World Health Organization Project page XM-DAC-30010-CHAI_CxCa Unitaid The project will catalyse the deployment of new technologies and products that offer the opportunity to make widespread scale up of screening and treatment for pre-cancerous lesions practical, affordable and achievable. Clinton Health Access Initiative Unitaid Operations Smiljka de Lussigny Programme Manager +41 22 791 12 00 unitaid@who.int https://unitaid.org/ Unitaid – Global Health Campus, Chemin du Pommier 40, 5th floor, 1218 Grand-Saconnex Geneva, Switzerland 2228644 25603816 26284078 40338386 22672348 2522868 251241256 200000 Unitaid Clinton Health Access Initiative (CHAI) 4000000 Unitaid CLINTON HEALTH ACCESS INITIATIVE 1062853 Unitaid Clinton Health Access Initiative, Inc 1732771 Unitaid CHAI / UNICEF SD 3000000 Unitaid Clinton Health Access Initiative, Inc 2600000 Unitaid Clinton Health Access Initiative (CHAI) 124171392 Grant Agreement Value. The value has been increased by $11,347,366 after amendment of May 2020 Unitaid CHAI 606280 Unitaid UNICEF SD 292000 Unitaid Clinton Health Access Initiative (CHAI) 3351692 Unitaid CHAI 3354171 Unitaid Clinton Health Access Initiative, Inc 585000 Unitaid CHAI / UNICEF SD 5612074 Unitaid CHAI 2343048 Unitaid CLINTON HEALTH ACCESS INITIATIVE 2085762 Unitaid Clinton Health Access Initiative 11253757 Unitaid Clinton Health Access Initiative 7800000 Unitaid Clinton Health Access Initiative 4065732 UNITAID Clinton Health Access Initiative 12734268 Clinton Health Access Initiative 3504000 Clinton Health Access Initiative 431235.89 Unitaid CHAI 2916000 Unitaid Clinton Health Access Initiative (CHAI) 4937147 Unitaid Clinton Health Access Initiative, Inc 2039990 Unitaid Clinton Health Access Initiative (CHAI) 10142109 Unitaid CHAI 4000000 Unitaid CHAI 4937147 Unitaid Clinton Health Access Initiative, Inc 5000000 Unitaid Clinton Health Access Initiative (CHAI) 7918124 Unitaid 495724 Unitaid Clinton Health Access Initiative (CHAI) 9416000 Unitaid CHAI 2131089 Unitaid XM-DAC-30010-MedSuRe Unitaid Medicines Supply Resilience Africa - Regional Manufacturing for Equitable Access The United States Pharmacopeial Convention, Inc. Mangwanya Faith Programme Manager mangwanyaf@who.int https://unitaid.org/ 4294480 12947959 9340764 6648705 2268092 3709556 Unitaid The United States Pharmacopeial Convention, Inc. 35500000 Unitaid The United States Pharmacopeial Convention, Inc. 1072953 Unitaid The United States Pharmacopeial Convention, Inc. XM-DAC-30010-Malaria-Enabler Unitaid The WHO Malaria Enabler Grant aims to gather evidence and develop policy on malaria innovations and ensure that better health products and approaches are widely available in all malaria endemic countries. World Health Organization Unitaid Luca Occhini Programme Manager occhinil@who.int https://unitaid.eu 132027 1063564 926814 977481 1594341 2288154 791668 1133838 1481827 1285472 Unitaid WHO 1884046 Unitaid WHO 1120042 UNITAID WHO 202270 Unitaid World Health Orgnaization 1069998 Unitaid World Health Organization 10098059 Grant Agreement Value 768000 Unitaid World Health Organization 283533 Unitaid World Health Organization 880644 Unitaid World Health Organization 995128 Unitaid World Health Organization 1134130 Unitaid World Health Organization - WHO 2121297 Unitaid World Health Organization - WHO 500000 Unitaid WHO 395000 Unitaid World Health Organization 725100 1325245 Unitaid World Health Organization XM-DAC-30010-VayuExplorePhase2 UNITAID For Commercialisation and Market Entry of the Vayu bCPAP and Low-Flow Blender Circuit Devices (Phase 2)Improve child survival with triage and treatment tools Vayu Global Health Innovations Mr Jackson HUNGU Programme Manager hunguj@who.int https://unitaid.org/#en 600000 1300000 1500000 1600000 500000 Unitaid Vayu Global Health Innovations 300000 Unitaid Vayu Global Health Innovations 500000 Unitaid Vayu 5000000 Unitaid Vayu Global Health Innovations 1000000 Unitaid Vayu 1000000 Unitaid Vayu Global Health Innovations 300000 Unitaid 300000 Unitaid Vayu Global Health Innovations 500000 Unitaid Vayu XM-DAC-30010-LONGEVITY UNITAID LONG acting pipeline to Establish medicines for malaria, tuberculosis and HCV with Infrastructure for sustainable Transitional capacity University of Liverpool Unitaid Hencher Katherine Programme Manager https://unitaid.org 2462202 4573768 4219157 2606519 3040181 12953409 14226796 4871290 213731 1500000 UNITAID University of Liverpool 41859700 Unitaid University of Liverpool 6500000 Unitaid University of Liverpool 3245229 Unitaid University of Liverpool 720274 Unitaid University of Liverpool 2240572 Unitaid University of Liverpool 5472380 Unitaid University of Liverpool 1734929 Unitaid University of Liverpool 5385000 Unitaid University of Liverpool 2900000 Unitaid University of Liverpool XM-DAC-30010-IPTI+ UNITAID Intermittent Preventive Treatment in Infants - Plus Population Services International (PSI) London School of Hygiene and Tropical Medicine Unitaid Yohannes Ambachew Programme Manager 41227911200 yohannesam@unitaid.who.int https://unitaid.org/#en 1017162 4127770 9911641 11305992 4394620 2734000 Unitaid Population Services International (PSI) 5406000 Unitaid Population Services International 35485084 Unitaid Population Services International 6640865 Unitaid Population Services International 7483000 Unitaid Population Services International (PSI) 2769516 Unitaid Populations Services International (PSI) 8000000 Unitaid Population Services International (PSI) 2260000 Unitaid Populations Services International (PSI) 309000 Unitaid Populations Services International (PSI) XM-DAC-30010-PAHO-CxCa UNITAID Increase access to screen and treat for cervical cancer and STIs THE PAN AMERICAN HEALTH ORGANIZATION DE LUSSIGNY Smiljka Programme Manager delussignys@unitaid.who.int https://unitaid.org/ 2180875 337870 1636000 Unitaid The Pan American Health Organization - PAHO 2518745 Unitaid The Pan American Health Organization - PAHO 538000 Unitaid The Pan American Health Organization - PAHO XM-DAC-30010-ACCEL UNITAID ACCEL - Accelerating Community Centered Equitable Lenacapavir for key populations in South Africa: A consortium for population impact Africa Health Research Institute Anna Bowman Programme Manager bowmana@who.int https://unitaid.org/ 5783742 8893525 7780177 22457444 Unitaid AHRI - Africa Health Research Institute 4627000 Unitaid AHRI - Africa Health Research Institute XM-DAC-30010-IPTRIPSWemos UNITAID IP-TRIPS Enabling Access – Medical Innovations For All Wemos Foundation Akko Eleveld Project Manager eleveldj@who.int https://unitaid.org/contact/#en 993753 1128729 1085765 1069345 4270000 Unitaid Stichting Wemos 1500000 Unitaid Stichting Wemos 1118308 Unitaid Stichting Wemos XM-DAC-30010-MPPIV UNITAID Improving quality of life by expanding equitable and sustainable access in LMICs to appropriate, affordable and quality-assured health products for HIV, TB, hepatitis and other co-infectious, including during health emergencies MPP Foundation Hungu Jackson Programme Manager jacksonh@who.int https://unitaid.org/ 5500827 5507873 5477520 Unitaid the Medicines Patent Pool Foundation 11013124 Unitaid the Medicines Patent Pool Foundation XM-DAC-30010-SCALEIT UNITAID Sustainable Community-driven Approaches for Lenacapavir PrEP Expansionwith Impact and cosT- effectiveness in Zambia UTH-HAP (University Teaching Hospitals of Ministry of Health of Zambia under the HIV/AIDS Program) Katherine Blumer Programme Manager blumerk@who.int https://unitaid.org/ 3174510 2473140 2736821 3303000 Unitaid UTH-HAP 8384470 Unitaid UTH-PAH XM-DAC-30010-SUPREMECHAI UNITAID Sustainable Equitable Care and Universal Resources for Eclampsia and Anemia Clinton Health Access Initiative Theoleyre Romane Programme Manager theoleyrer@unitaid.who.int https://unitaid.org/ 6178779 7684926 7221304 5377734 26462743 Unitaid Clinton Health Access Initiative, Inc. 4940420 Unitaid linton Health Access Initiative, Inc. XM-DAC-30010-SUPREME UNITAID Ensuring Essential Lifesaving Tools for PreEclampsia and Maternal Anemia Amref Health Africa in Kenya THEOLEYRE, Romane Programme Manager theoleyrer@unitaid.who.int https://unitaid.org/ 6151343 7004427 6606186 6238044 26000000 Unitaid Amref Health Africa 4921074 Unitaid Amref Health Africa XM-DAC-30010-INNOVATEPATH UNITAID Innovations for Enhanced Access to Oxygen (INNOVATE)Improve quality of clinical care packages for global health emergencies – Medical Oxygen PATH Thomas Gradel Programme Manager gradelt@who.int https://unitaid.org/ 3644479 7821624 4620609 3953306 2734000 Unitaid PATH 19043391 Unitaid PATH XM-DAC-30010-Solidarity UNITAID The Solidarity project International Treatment Preparedness Coalition (ITPC) Mr Akko ELEVELD Programme Manager eleveldj@unitaid.who.int https://unitaid.org/#en 3873935 4760926 4441957 2980860 3505000 Unitaid International Treatment Preparedness Coalition Global NPC - ITPC 3026762 Unitaid International Treatment Preparedness Coalition Global NPC (ITPC) 5150000 Unitaid International Treatment Preparedness Coalition Global NPC (ITPC) 14170000 Unitaid International Treatment Preparedness Coalition Global NPC (ITPC) XM-DAC-30010-PAHO_Enabler_MNCH UNITAID To complement to the Fiotec/Fiocruz led Consortium for the project "Towards Elimination of Congenital Transmission of Chagas Disease in Latin America (CUIDA Chagas) and falls under the Area for Intervention (AfI) Towards the elimination of congenital infection in Chagas disease through better tools for diagnosis and treatment. THE PAN AMERICAN HEALTH ORGANIZATION Dessie Tarlton Programme Manager 0041227911200 tarltond@who.int https://unitaid.org/#en 202423 525782 647257 667367 457172 304780 Unitaid The Pan American Health Organisation - PAHO 852397 Pan American Health Organization (PAHO) 250000 Unitaid 2500000 Unitaid The Pan American Health Organization 298735 Unitaid THE PAN AMERICAN HEALTH ORGANIZATION 394088 Unitaid The Pan American Health Organisation - PAHO 400000 Unitaid The Pan American Health Organisation - PAHO XM-DAC-30010-PIH-ARCTB UNITAID Accelerate access to new TB detection tools Partners in Health Thomas Gradel Unitaid project lead https://unitaid.org/ 1221958 3322299 1838983 344490 1296276 Unitaid Partners in Health 1874224 Unitaid Partners in Health 7270000 Unitaid Partners in Health - PIH 1503040 Unitaid Partners in Health - PIH XM-DAC-30010-START-4-ALL UNITAID Start taking actionfor TB diagnosis (START 4 All) Liverpool School of Tropical Medicine De Lussigny Smiljka Programme Manager delussignys@unitaid.who.int https://unitaid.org/#en 108805 1405448 3564414 1709063 6378284 1441200 2833000 Unitaid Liverpool School of Tropical Medicine (LSTM) 14800000 Unitaid Liverpool School of Tropical Medicine (LSTM) 350000 Unitaid Liverpool School of Tropical Medicine (LSTM) 4420000 Unitaid Liverpool School of Tropical Medicine 1534400 Unitaid Liverpool School of Tropical Medicine (LSTM) 2400000 Unitaid Liverpool School of Tropical Medicine XM-DAC-30010-DriveDx4TB UNITAID Accelerate access to new TB detection tools: Overview The Aurum Institute NPC NGWIRA Chikosa ngwirac@who.int https://unitaid.org/ 572093 4497118 3175592 1974574 1488154 11800000 Unitaid The Aurum Institute 11648 Unitaid The Aurum Institute 2190000 Unitaid The Aurum Institute 2195000 Unitaid The Aurum Institute XM-DAC-30010-CombatDR-TB UNITAID Community-Driven Approaches for Transformative Change to Combat DR-TB (Combat DR-TB) Kenya Legal and Ethical Issues Network on HIV and AIDS (KELIN) Thomas Gradel Programme Manager gradelt@who.int https://unitaid.org/ 596215 1434067 748732 68385 1023000 Unitaid Kenya Legal and Ethical Issues Network on HIV and AIDS (KELIN) 590729 Unitaid Kenya Legal and Ethical Issues Network on HIV and AIDS (KELIN) 3020000 Unitaid Kenya Legal and Ethical Issues Network on HIV and AIDS (KELIN) 660000 Unitaid Kenya Legal and Ethical Issues Network on HIV and AIDS (KELIN) XM-DAC-30010-STOP-AMDR UNITAID Improve access to quality case management Johns Hopkins University Yohannes Ambachew Programme Manager yohannesam@unitaid.who.int https://unitaid.org/ 1993240 11839226 6908547 4023813 1056879 4200000 Unitaid Jhpiego Corporation Vayu 26536625 Unitaid Jhpiego Corporation 5451000 Unitaid Johns Hopkins University XM-DAC-30010-IP-TRIPS-TWN UNITAID Mobilizing for Equitable Access Third World Network Akko Eleveld Project Manager eleveldj@unitaid.who.int https://unitaid.org/#en 1203525 1445531 1905999 1495713 6170000 Unitaid Third World Network 2200000 Unitaid Third World Network 1405000 Unitaid Third World Network 273500 Unitaid Third World Network 950202 Unitaid Third World Network Berhad (TWN) XM-DAC-30010-HIVHCVEnabler UNITAID This enabling project aims to ensure that outputs from UNITAID’s investments in the areas of HIV and hepatitis C virus (HCV) are translated into public health policy and ultimately have global impact. World Health Organization Unitaid Katherine Hencher Programme Manager +41 22 791 12 00 hencherk@unitaid.who.int Chemin de Blandonnet 10 – BIBC III – 8th Floor 1214 Vernier, Switzerland 1410847 4502187 5356952 4398858 2996682 6856504 3848582 4332584 6394782 1748000 Unitaid World Health Organization 1849803 CxCA Unitaid World Health Organization 61896 CxCA intiative Unitaid World Health Organization - WHO 5275383 Unitaid WHO 1849803 Unitaid World Health Organization 2560000 Unitaid World Health Organization 247730 AFRO initiative Unitaid World Health Organization - WHO 193117 South Africa initiative Unitaid World Health Organization - WHO 613657 World Health Organization (WHO) Unitaid World Health Organization (WHO) World Health Organization (WHO) World Health Organization (WHO) 350000 HIV Enabler -DRC Mpox activities Unitaid World Health Organization 4546419 Unitaid WHO 24535756 Grant Agreement Value Unitaid World Health Organization 2500000 Unitaid WHO 3596125 UNITAID WHO 288703 Unitaid World Health Organization 335000 Unitaid World Health Organization 554511 Unitaid World Health Organization (WHO) 432645 Unitaid World Health Organization - WHO 10800000 Unitaid World Health Organization 1988790 Unitaid World Health Organization 3950631 Unitaid World Health Organization 1000000 Unitaid World Health Organization 1722475 Unitaid World Health Organization 1564899 Unitaid World Health Organization 781000 Unitaid World Health Organization 62150 Unitaid World Health Organization XM-DAC-30010-WitsPrEP UNITAID The objectives of this grant are to increase accessibility of PrEP for eligible adolescent population in the project implementation areas; demonstrate effective delivery models and appropriate use of PrEP amongst adolescents; generate and disseminate evidence on the use of PrEP in adolescence. Wits Reproductive Health and HIV Institute Unitaid Heather Ingold Programme Manager +41 22 791 12 00 ingoldh@unitaid.who.int https://unitaid.eu 1351536 2700244 2666113 3162880 3314725 3479174 5055665 10000000 10000000 9840204 1579547 Unitaid Wits Health Consortium (Pty) 1420453 Unitaid Wits Reproductive Health and HIV Institute (Wits RHI) 1000000 Unitaid Wits Health Consortium (Pty) Ltd on behalf of Wits Reproductive Health and HIV Institute (Wits RHI) 1000000 Unitaid Wits Health Consortium (Pty) 5553000 Unitaid Wits Health Consortium (Pty) 1074618 Unitaid Wits Health Consortium (Pty) Ltd on behalf of Wits Reproductive Health and HIV Institute(Wits RHI) 51570540 Grant Agreement Value Wits Reproductive Health and HIV institute 2200000 Unitaid Wits Health Consortium (Pty) Ltd 1415578 Unitaid Wits Health Consortium (Pty) 2864176 Wits Reproductive Health and HIV institute 120000 Unitaid Wits University 4000000 Unitaid Wits RHI, a Division of Wits Health Consortium (Pty) Ltd 600999 Unitaid Wits 4405000 Unitaid : Wits RHI, a Division of Wits Health Consortium (Pty) Ltd 4560000 Unitaid Wits Health Consortium 2131000 Unitaid Wits University 400000 Unitaid Wits Reproductive Health and HIV Institute (Wits RHI) 2040000 Unitaid Wits Health Consortium (Pty) 2784165 Unitaid Wits Reproductive Health and HIV Institute 2000000 Unitaid Wits Reproductive Health and HIV Institute (Wits RHI) 615000 Unitaid Wits Reproductive Health and HIV Institute (Wits RHI) 286215 Wits Reproductive Health and HIV Institute (Wits RHI) XM-DAC-30010-PAHO-EVT UNITAID Improve access to better tools for safe pregnancy and birth for women and newborns – EVT THE PAN AMERICAN HEALTH ORGANIZATION Ferris Danielle ferrisd@who.int https://unitaid.org/ 59890 322598 171218 171218 68749 800130 Unitaid The Pan American Health Organization - PAHO 116028 Unitaid The Pan American Health Organization - PAHO 90972 Unitaid Pan American Health Organisation 239019 Unitaid The Pan America Health Organization - PAHO XM-DAC-30010-FIOTECPrEP UNITAID The main goal of the project is to contribute to the reduction in HIV incidence among MSM and TGW in Brazil, Mexico and Peru through the inclusion of PrEP as a component of comprehensive HIV prevention provided by public services. Foundation for Scientific and Technological Development in Health (FIOTEC) Unitaid Anna Hellstrom Programme Manager hellstroma@unitaid.who.int https://unitaid.eu 813089 3456666 6547437 5387536 5529298 3710153 4619066 5352719 2587564 3327073 2144913 6530638 Unitaid FIOTEC 667000 Unitaid FIOTEC 200000 Unitaid FIOTEC – FUNDAÇÃO PARA O DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO EM SAÚDE 253000 UNIVERSIDAD PERUANA CAYETANO HEREDIA - UPCH 1824627 Unitaid FIOTEC - Fundação para o Desenvolvimento Científico e Tecnológico em Saúde 475000 Unitaid FIOTEC – FUNDAÇÃO PARA O DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO EM SAÚDE 170047 Unitaid Universidad peruana Cayetano Heredia 1100000 Unitaid FIOTEC 232000 Unitaid UNFPA 26355192 967000 Unitaid FIOTEC 450000 Unitaid FIOTEC - UNFPA 129016 Unitaid Universite Peruana 400000 FIOTEC 1636364 Unitaid FIOTEC 490591 Unitaid UNFPA 1551337 Unitaid Universidad Peruana 4238747 Unitaid Foundation for Scientific and Technological Development in Health (FIOTEC) 1368598 Unitaid United Nations Population Fund 215000 Unitaid United Nations Population Fund 614000 Unitaid Universidade Peruana Cayetano Heredia 700000 Unitaid UNFPA 516000 Unitaid UPCH - UNIVERSIDAD PERUANA CAYETANO HEREDIA 431000 Unitaid UNFPA 2845000 Unitaid Fiotec 1300000 Unitaid Universidad Peruana Cayetano Heredia (UPCH) 250000 Unitaid UNFPA 540067 Unitaid Fundação para o Desenvolvimento Científico e Tecnológico em Saúde (FIOTEC) 337000 Unitaid UNFPA 2115390 Unitaid FIOTEC – FUNDAÇÃO PARA O DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO EM SAÚDE 200000 UNITAID Universidad peruana Cayetano Heredia (UPCH) 300000 Unitaid FIOTEC - Fundação para o Desenvolvimento Científico e Tecnológico em Saúde 40654.13 Unitaid Fundacao para o Desenvolvimento Cientifico e Tecnologico em Saude - FIOTEC 100100 Unitaid Universidad Peruana Cayetano Heredia 1841557 Unitaid FIOTEC 3287946 Unitaid FIOTEC - Fundacao para o Desenvolvimento Cientifico e Tecnologico em Saude 1000000 Unitaid 269526 Unitaid Universidad Peruana Cayetano Heredia 1300000 Unitaid Fiotec 300000 Unitaid UNFPA 400000 Unitaid UPCH - UNIVERSIDAD PERUANA CAYETANO HEREDIA 260000 UNITAID UNFPA 1679562 Unitaid FIOTEC - Fundação para o Desenvolvimento Científico e Tecnológico em Saúde 2436000 Unitaid Fundação para o Desenvolvimento Científico e Tecnológico em Saúde (FIOTEC) 2115390 Unitaid Fundacao para o Desenvolvimento Cientifico e Tecnologico em Saude - FIOTEC 66321 Unitaid Universidad Peruana Cayetano Heredia 600000 Unitaid Fundacao para o Desenvolvimento Cientifico e Tecnologico em Saude - FIOTEC 9869791 Unitaid FIOTEC - Fundacao para o Desenvolvimento Cientifico e Tecnologico em Saude 1000000 Unitaid FIOTEC - Fundacao para o Desenvolvimento Cientifico e Tecnologico em Saude 2000000 Unitaid Fiotec XM-DAC-30010-SUN UNITAID The project aims to increase the number of children with MDR-TB treated with better medicines resulting in reduced morbidity and mortality through addressing the remaining persistent knowledge gaps on TB drug PK in children and the development of appropriate formulations of drugs used for MDR-TB treatment. Stellenbosch University Unitaid Operations Ngwira Chikosa Programme Manager 41227911200 unitaid@who.int https://unitaid.org/ Unitaid – Global Health Campus, Chemin du Pommier 40, 5th floor, 1218 Grand-Saconnex Geneva, Switzerland 462420 3014284 3990489 3976986 3155227 4355699 1050138 852000 Unitaid University of Stellenbosch 1000000 Unitaid Stellenbosch University 1565290 Unitaid Stellenbosch University 531234 Unitaid Stellenbosch University 491019 Unitaid Stellenbosch University 4568898 Unitaid Stellenbosch University 5000000 Unitaid The University of Stellenbosch 3210139 Unitaid Stellenbosch University 20565362 Stellenbosch University 1630472 Unitaid University of Stellenbosch 308001 Unitaid Stellenbosch University XM-DAC-30010-MDx UNITAID Accelerate access to new TB detection tools: Overview Clinton Health Access Initiative NGWIRA Chikosa Programme Manager ngwirac@who.int https://unitaid.org/ 3152544 3612941 1935070 8994789 Unitaid Clinton Health Initiative, Inc. 3100000 Unitaid Clinton Health Initiative, Inc. 3190000 Unitaid Clinton Health Initiative, Inc. - CHAI XM-DAC-30010-TRANSFORM UNITAID TRANSFORM -Tranexamic acid accessforall mothers with bleeding after childbirth London School of Hygiene and Tropical Medicine Kate Hencher Programme Manager 41227911200 hencherk@who.int https://unitaid.org/#en 97109 1226266 2653545 3445610 3359495 1627519 1299810 Unitaid London School of Hygiene and Tropical Medicine 12417840 Unitaid London School of Hygiene and Tropical Medicine 2863483 Unitaid London School of Hygiene and Tropical Medicine 2002764 Unitaid London School of Hygiene and Tropical Medicine 2837320 Unitaid London School of Hygiene and Tropical Medicine 1819335 Unitaid London School of Hygiene and Tropical Medicine XM-DAC-30010-AHD-PAHO UNITAID Preventing Deaths among adults and children by optimizing advanced HIV disease management THE PAN AMERICAN HEALTH ORGANIZATION Unitaid Yamuna Mundade Programme Manager mundadey@who.int https://unitaid.org/ 274745 2143946 2222167 4996219 Unitaid The Pan American Health Organisation - PAHO 2997731 Unitaid The Pan American Health Organisation - PAHO 960000 Unitaid The Pan American Health Organisation - PAHO 1038487 Unitaid The Pan American Health Organisation - PAHO XM-DAC-30010-THRIVE-CHAI UNITAID THRIVE (Transforming Advanced HIV Disease CaRe in LMICs through ComprehensiVe and Equitable Access) Clinton Health Access Initiative Kristiansson Charlotte Programme Manager kristianssonc@unitaid.who.int https://unitaid.org/#en 4472769 7986875 10047117 365854 4000000 Unitaid Clinton Health Access Initiative, Inc. (CHAI) 4225500 Unitaid Clinton Health Access Initiative, Inc. (CHAI) 7997051 Unitaid Clinton Health Access Initiative, Inc. (CHAI) 20353998 Unitaid Clinton Health Access Initiative, Inc. (CHAI) 4418000 Unitaid Clinton Health Access Initiative, Inc. (CHAI) XM-DAC-30010-AMPLI-PPHI-Expansion UNITAID Improve access to better tools for safe pregnancy and birth for women and newborns Jhpiego Maria Donatelli Programme Manager donatellim@who.int https://unitaid.org/#en 867705 2616435 1970893 499699 Unitaid Jhpiego Corporation 1150540 Unitaid Jhpiego Corporation 1976287 Unitaid Jhpiego Corporation 2587410 Unitaid Jhpiego Corporation 5944400 Unitaid Jhpiego - The Johns Hopkins University 1803000 Unitaid Jhpiego CorporationOriginal project 1088854 Unitaid Jhpiego Corporation. SBA XM-DAC-30010-ASCENT_KNCV UNITAID The project will increase access to more cost-effective, fit-for-purpose and comprehensive digital adherence technologies (DATs) in low and middle-income countries (LMICs). Koninklijke Nederlandse Centrale Vereniging tot bestrijding der Tuberculose (KNCV) Unitaid Operations Yamuna Mundade Programme Manager +41 22 791 12 00 unitaid@who.int https://unitaid.org/ Unitaid – Global Health Campus, Chemin du Pommier 40, 5th floor, 1218 Grand-Saconnex Geneva, Switzerland 785276 3226004 3937111 3770424 2077806 2157170 3353893 5455654 2400000 Unitaid Koninklijke Nederlandse Centrale Vereniging tot bestrijding der Tuberculose (KNCV) 1531560 Unitaid KNCV TUBERCULOSIS FOUNDATION 1603677 Unitaid KNCVKoninklijke Nederlandse Centrale Vereniging tot bestrijding der Tuberculose 3966171 Unitaid KNCV 2747713 Unitaid KNCV TUBERCULOSIS FOUNDATION 570332 Unitaid KNCV TUBERCULOSIS FOUNDATION - KNCV 5015657 KNCV TUBERCULOSIS FOUNDATION 24998007 Grant Agreement Value Unitaid KNCV 2300000 Unitaid Koninklijke Nederlandse Centrale Vereniging tot bestrijding der Tuberculose (KNCV) 1190350 Unitaid KNCV TUBERCULOSIS FOUNDATION 2000000 Unitaid Koninklijke Nederlandse Centrale Vereniging tot bestrijding der Tuberculose (KNCV) 655000 Unitaid Koninklijke Nederlandse Centrale Vereniging tot bestrijding der Tuberculose (KNCV) XM-DAC-30010-HEPCIII UNITAID Innovate, Involve, Inspire: Preventing Hepatitis C Through Community-Led Harm Reduction (HEPC III) Frontline AIDS Akko Eleveld Programme Manager 41227911200 https://unitaid.org/#en 787692 2791313 2983823 2656090 585969 Unitaid Frontline AIDS 2064359 Unitaid Frontline AIDS 9218918 Unitaid Frontline AIDS 3811431 Unitaid Frontline AIDS 2107544 Unitaid Frontline AIDS XM-DAC-30010-MADE UNITAID Manufacturing to Accelerate Diagnostic Excellence (MADE) in Africa PATH Faith Maangwanya Programme Manager mangwanyaf@who.int https://unitaid.org/ 710047 3804146 2389874 2626622 955027 11050000 Unitaid PATH 1274331 Unitaid PATH 4372205 Unitaid PATH XM-DAC-30010-CANVeCT UNITAID Introduce and optimize prevention tools: Vector control Centre for Research in Infectious Diseases (CRID) Rachel Evans Programme Manager evansr@unitaid.who.int https://unitaid.org/ 329379 4041878 4134074 4540239 3026221 1085603 18135853 Unitaid Centre for Research in Infectious Diseases (CRID) 696818 Unitaid Centre for Research in Infectious Diseases (CRID) 62865 Unitaid Liverpool School of Tropical Medicine 15277 Unitaid London School of Hygiene and Tropical Medicine 119737 Unitaid Centre National de Recherche et de Formation du Paludisme - CRID 62689 Unitaid London School of Hygiene and Tropical Medicine XM-DAC-30010-SUCCESS-FAP UNITAID Increase access to screen and treat for cervical cancer and STIs expertise france DE LUSSIGNY, Smiljka Programme Manager delussignys@unitaid.who.int https://unitaid.org/ 1050519 1249480 1051000 Unitaid Expertise France 3241000 Unitaid Expertise France 760000 Unitaid Expertise 2300000 Unitaid Expertise France XM-DAC-30010-SUCCESS UNITAID TBD France Expertise International (FEI) Unitaid Smiljka de Lussigny Programme Manager +4122791200 https://unitaid.org/ Unitaid – Global Health Campus, Chemin du Pommier 40, 5th floor, 1218 Grand-Saconnex Geneva, Switzerland 119287 3184031 5912404 7511921 6076952 3272875 2605357 683767 6000000 Unitaid Expertise France 5758172 Unitaid Expertise France 7004000 Unitaid Expertise France 860000 Unitaid Expertise France 4700000 Unitaid Expertise France 1416000 Unitaid Expertise France 28976470 France Expertise Internationale (FEI) 466000 Unitaid Expertise France XM-DAC-30010-CUTTS-HEPC UNITAID Catalyse uptake of Under-utilised Tools & Treatment Simplification for HEP C (CUTTS HepC) Medecins du Monde France Akko Elveld Programme Manager 41227911200 eleveldj@who.int https://unitaid.org/#en 1092473 2030088 2799138 2696585 1316303 157031 2127734 Unitaid Médecins du Monde 2272445 Unitaid Médecins du Monde 9363092 Unitaid Médecins du Monde 2719713 Unitaid Médecins du Monde 2582653 Unitaid Médecins du Monde XM-DAC-30010-RESPECT UNITAID Accelerate access to new TB detection tools STOP TB Programme Manager Programme Manager Programme Manager Programme Manager gradelt@who.int https://unitaid.org/ Programme Manager 1063946 2322590 782644 1900000 Unitaid UNOPS (ON BEHALF OF STOP TB PARTNERSHIP 4988423 Unitaid StopTB 1200000 Unitaid StopTB 1375000 Unitaid StopTB XM-DAC-30010-CUIDA UNITAID CUIDA (Towards Elimination of Congenital Transmission of Chagas Disease in Latin America Foundation for Scientific and Technological Development in Health (FIOTEC) Unitaid Danielle Ferris Programme Manager 41227911200 tarltond@unitaid.who.int https://unitaid.org/contact/#en 159205 1090630 2115734 2248144 3983234 3122943 50000 Unitaid FUNDACION COMUNITARIA CIRD 500000 Unitaid INSTITUTO NACIONAL DE SALUD - INS 473188 Unitaid FUNDACIÓN COMUNITARIA CENTRO DE INFORMACIÓN Y RECURSOS PARA EL DESARROLLO, CIRD 640286 Unitaid FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS (FIND) 1000000 Unitaid FIOTEC – FUNDAÇÃO PARA O DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO EM SAÚDE 510000 Unitaid FIOTEC – FUNDAÇÃO PARA O DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO EM SAÚDE 479985 Unitaid FIOTEC 160502 Unitaid FUNDACIÓN COMUNITARIA CENTRO DE INFORMACIÓN Y RECURSOS PARA EL DESARROLLO, CIRD 15000000 FIOTEC 207684 Unitaid FIOTEC – Fundação para o Desenvolvimento Científico e Tecnológico em Saúde 566089 Unitaid UNDP Bolivia 155481 Unitaid FIOTEC - Fundação para o Desenvolvimento Científico e Tecnológico em Saúde 205420 Unitaid FIOTEC – Fundação para o Desenvolvimento Científico e Tecnológico em Saúde 193157 Unitaid Foundation for Innovative New Diagnostics - FIND 138627 Unitaid FUNDACIÓN COMUNITARIA CENTRO DE INFORMACIÓN Y RECURSOS PARA EL DESARROLLO, CIRD 150000 Unitaid FIOTEC - Fundação para o Desenvolvimento Científico e Tecnológico em Saúde 325590 Unitaid Fundacion Comunitaria Centro de Informacion y Recursos - CIRD 700000 Unitaid UNDP Bolivia 500000 Unitaid FIOTEC – FUNDAÇÃO PARA O DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO EM SAÚDE 180000 Unitaid Fundacion Comunitaria Centro de Informacion y Recursos - CIRD 800000 Unitiad UNDP - United Nations Development Programme (Administrative Agent for INLASA) 400000 Unitaid Instituto Nacional de Salud (INS) 600000 Unitaid FIOTEC – FUNDAÇÃO PARA O DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO EM SAÚDE 250000 Unitaid Fundaçâo para o Desenvolvimento Científico e Tecnológico em Saúde - FIOTEC 479985 Unitaid FIOTEC – FUNDAÇÃO PARA O DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO EM SAÚDE 173245 Unitaid Foundation for Innovative New Diagnostic (FIND) 566090 Unitaid UNDP/INLASA 600000 Unitaid UNDP/INLASA 155000 Unitaid CIRD - Fundacion Comunitaria Centro de Informacion y Recursos 570000 Instituto Nacional de Salud - INS XM-DAC-30010-IMPAACT4HIV UNITAID IMproved Access to AHD Care and Treatment 4HIV / IMPAACT4HIV The Aurum Institute NPC Anna Hellstrom Programme Manager hellstroma@unitaid.who.int https://unitaid.org/#en 2637201 4581676 8125529 2670592 17490120 Unitaid The Aurum Institute NPC 4000000 Unitaid The Aurum Institute NPC 2000000 Unitaid The Aurum Institute NPC 2976000 Unitaid The Aurum Institute NPC 2237000 Unitaid The Aurum Institute NPC 1500000 Unitaid The Aurum Institute NPC 1000000 Unitaid The Aurum Institute NPC 2140400 Unitaid The Aurum Institute NPC